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ANALYSIS OF A NON-CANONICAL ANTIVIRAL MECHANISM IN WEST NILE VIRUSINFECTED MOUSE CELLS

by

DAN CUI
Under the Direction of Margo Brinton, Ph.D.

ABSTRACT
Upon viral infection, host cells produce type I interferon (IFN), which activates the JAKSTAT signaling pathway and induces the expression of hundreds of interferon-stimulated genes
(ISGs) to establish an antiviral state. In West Nile virus (WNV)-infected cells, the JAK-STAT
signaling pathway is blocked by viral proteins. However, the expression of a subset of ISGs,
which includes 2-5-oligoadenylate synthetase 1a (Oas1a), Oas1b, interferon regulatory factor 7
(Irf7), Mx1, and interferon-induced proteins with tetratricopeptide repeats 1 (Ifit1), is still
upregulated by an IFN-independent mechanism in WNV-infected mouse embryonic fibroblasts
(MEFs). Studies in cells with one or more components of RNA-sensing pathway knocked out

showed that the alternative ISG upregulation is activated through RIG-I or MDA5, and the
downstream adaptor IPS-1. In cells with IRF3, 5 and 7 knocked out, the alternative ISG
upregulation by WNV infection is reduced but not eliminated. As an initial means of discovering
the transcription factors involved in this non-canonical ISG upregulation, the critical regulatory
regions in the promoters of two representative ISGs, Oas1b and Ifit1, were mapped using a dual
luciferase assay system with a NanoLuc luciferase promoter reporter in WNV-infected Ifnar1-/MEFs. The region from -299 to -28 in the Oas1b promoter, and the region from -192 to -50 in
the Ifit1 promoter were identified as being important for upregulating non-canonical gene
expression after WNV infection. Fine mapping identified enhancer and repressor sub-regions as
well as transcription factor binding sites (TFBSs) putatively involved in the IFN-independent
antiviral mechanism. Mutation of one identified TFBS in the ISG promoters reduced Oas1b and
Ifit1 promoter activities. In electrophoretic mobility shift assays (EMSAs), a unique band, which
was detected in WNV-infected but not in mock-infected Ifnar1-/- MEF nuclear extracts, was not
observed when a probe with the identified TFBS mutated was used, suggesting that a unique
complex forms at the identified TFBS when it is in the context of the adjacent flanking regions.
The unique complex appears to contain NF-κB components and IRF3, IRF5 or IRF7. Our
findings provide new insights into the mechanism involved in non-canonical upregulation of
ISGs after WNV infection.
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1
1.1

INTRODUCTION

Flaviviruses

1.1.1 Genus Flavivirus
The family Flaviviridae currently contains four genera: Flavivirus, Hepacivirus,
Pestivirus, and Pegivirus. The genus Flavivirus includes viruses transmitted by blood-feeding
arthropods, several of which are emergent or re-emergent pathogens that are found on six
continents. Viruses in this genus include dengue virus (DENV), yellow fever virus (YFV),
Japanese encephalitis (JEV), tick-borne encephalitis viruses (TBEV), West Nile virus (WNV),
and the recently emerged pathogen, Zika virus (ZIKV). Flavivirus infections in humans are
responsible for significant morbidity and mortality (Fields et al., 2013; Daep et al., 2014).
1.1.2 Flavivirus genome characteristics and replication
Flaviviruses are enveloped viruses with an ~11-kb positive-sense, single-stranded RNA
genome that encodes a single open reading frame with highly structured 5′ and 3′ flanking
untranslated regions (UTR). The flavivirus genome has a 5′ type 1 cap structure, as do eukaryotic
cell mRNAs. However, unlike the eukaryotic host mRNA, the flavivirus genome RNA does not
contain a 3′ poly-A. The flavivirus replication life cycle begins with virion attachment to cell
surface receptors, endocytosis, and fusion with the endosomal membrane resulting in the release
of the viral genome RNA into the cytoplasm. The genome is translated by host machinery as a
single polyprotein, which is subsequently cleaved by host and viral proteases to generate three
structural [capsid (C), premembrane (prM), and envelop (E)] and seven non-structural (NS1,
NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins. The non-structural proteins form the
replication complex that is required for viral RNA synthesis on ER membrane. The nascent
genome RNA is encapsidated by ER-membrane associated structural proteins. Following virion
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assembly and transport through the host cellular secretory pathway, mature viral particles are
released by exocytosis from an infected cell (Brinton, 2002). All tested viruses in the genus
Flavivirus, including WNV, DEVN, TBEV, and YFV, also produce a unique 3′ noncoding
subgenomic RNA (sfRNA) in infected cells, which is generated by cellular 5′ to 3′ exonuclease
XRN1 digestion of genome RNA that is terminated by an RNA structure located RNA 3′ UTR
(Funk et al., 2010; Chapman et al., 2014). The role of the sfRNA in the flavivirus replication
cycle is not clear. However, it was shown that sfRNA contributes to flavivirus pathogenicity and
evasion of the host immune response (Roby et al., 2014).
1.1.3 Enzootic cycle and pathogenicity of WNV
WNV is a mosquito-borne virus that is present in Africa, Eastern Europe and the
Mediterranean region, Russia, the Middle East, India, Australia, and the Americas. It was first
discovered in the West Nile district of Uganda in 1937 (Kramer et al., 2008). WNV emerged in
New York City in the summer of 1999, then spread throughout the United States within four
years and has continued to cause seasonal outbreaks (Komar, 2003; Reisen, 2013). In nature,
WNV is maintained in a transmission cycle between birds and mosquitos, predominantly Culex
mosquito species that prefer to bite birds over humans. However, WNV is sometimes transmitted
to a person by a mosquito bite. Unlike DENV- or ZIKV-infected humans, humans infected with
WNV are dead-end hosts and not part of the enzootic cycle because they have low viremia
levels. Although WNV infections in humans are usually asymptomatic, some people develop
fever and flu-like symptoms and less than 1 % of WNV-infected patients develop neurological
diseases, such as encephalitis, meningitis, or poliomyelitis. Older adults are at greater risk of
developing severe symptoms (Dauphin and Zientara, 2007). The central nervous system damage
caused by a WNV infection is non-reversible. The study of WNV-host interactions provides
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valuable insights for the development of vaccines and the identification of targets for antiviral
drug development.
WNV infections in human are usually the result of a mosquito bite. During bloodfeeding, mosquitos inject their saliva into human skin, which contains WNV particles and some
molecules that reduce inflammation and alter host immunity (Titus et al., 2006). WNV
pathogenesis in humans is not well characterized, but studies in rodent models have provided
some insights. Following a mosquito bite, WNV replicates in local skin cells, including
keratinocytes, dermal dendritic cells (DCs), and Langerhans cells. After DC migration, viral
particles infect the regional draining lymph node, and subsequently migrate in the blood to the
spleen, cross the blood brain barrier (BBB) and infect the central neural system (CNS) causing
neuron damage (Suthar et al., 2013). Host innate and adaptive immune responses work together
to clear a WNV infection and limit possible damage due to an immune response.
1.1.4 WNV strain diversity
Based on the comparison of the amino acid sequences of the envelope protein, WNV
isolates have been divided into lineage1 and lineage 2 (Berthet et al., 1997). Lineage 1 consists
of strains that are often associated with outbreaks of human encephalitis and meningitis,
including NY99 and Eg101 (Lanciotti et al., 1999; Brinton, 2002). A WNV strain that is
endemic to Australia and Asia, Kunjin virus, also belongs to lineage 1 but has an attenuated
phenotype in humans (Beasley et al., 2005). Lineage 2 strains are restricted to Africa and are
usually less pathogenic, but several recent neuroinvasive cases associated with endemic lineage 2
WNV suggest that the virulence of WNV strains in this linage may be underestimated (Venter
and Swanepoel, 2010). Recent studies of the genome sequences of additional WNV isolates
suggest that some WNV isolates cannot be grouped into lineage 1 or 2. A phylogenetic analysis
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that used partial genome sequences (C-prM-E) added three additional genetic lineages for WNV
strains (Bakonyi et al., 2005; Bondre et al., 2007). Because only a few isolates have recently
been found for lineages 3, 4, and 5, little is known about their phenotypes (Suthar et al., 2013).
1.1.5 WNV replication cycle
The cell surface receptor(s) used for WNV attachment and entry is unknown (Brinton,
2002; 2014). WNV particles enter cells via receptor-mediated endocytosis, and viral RNA is
released into the cell cytoplasm following fusion of the viral and cellular endosomal membranes.
The WNV genome encodes three structural proteins (C, prM, E) and seven non-structural
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5). Many of the non-structural proteins
have multiple functions, but all contribute to facilitate virus RNA replication. The 3′ and 5′
terminal regions of the WNV genome has been shown to interact with each other to regulate viral
minus strand RNA replication, and interaction between some cell proteins and the terminal viral
RNAs may promote virus RNA replication (Brinton and Basu, 2015).
1.2

Host cell interferon (IFN) antiviral response
The IFN response serves as an essential component of mammalian cell innate antiviral

defense. IFN was first described by Alick Isaacs and Jean Lindenmann in 1957 as a phenomenon
of “conditions that disrupted virus information” (Isaacs and Lindenmann, 1957). In the 1970s, it
was found that there is a family of IFN proteins. During the next two decades, it was
demonstrated that IFNs were not only effective in defending against virus diseases and cancer
but also for treating multiple sclerosis (MS). As the intercellular molecular events involved in the
production of IFN as well as the intercellular networks stimulated by IFN being elucidated, it
became clear that IFNs are fundamental components of the innate immune system (Borden et al.,
2007). To date, three types of IFNs (type I, III, III) have been identified.
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Either the incoming virion or viral genome or viral molecules produced in infected cells
are sensed by host cell sensors, called pattern recognition receptors (PPRs). These membranebound or cytoplasmic PPRs activate downstream signaling pathways that lead to the production
of different kinds of cytokines and chemokines. Secreted IFNs are important cytokines that bind
to cell surface IFN receptors, activate signaling pathways and induce an antiviral state in infected
and uninfected cells by upregulating the expression of hundreds of interferon-stimulated genes
(ISGs). The antiviral function of these ISGs establishes an antiviral state, forming the first line of
immune response to virus infection. The IFN response in host cells is classified into three phases:
induction of IFN expression, activation of the IFN effector pathway, and expression of ISGs.
1.2.1 Host PPRs that induce IFN expression after a flavivirus infection
The membrane-bound and cytoplasmic PRRs in mammalian cells serve as a sophisticated
immune surveillance network to sense unique features of invading viral pathogens. Unique
features of viruses, termed pathogen-associated molecular patterns (PAMPs), include viral
nucleic acids, proteins and carbohydrates (Brennan and Bowie, 2010; Wilkins and Gale, 2010).
Three major classes of PPRs have been shown to contribute to efficient detection of a flavivirus
infection. IFNs are induced through the signaling pathways downstream of an activated PRR
after virus infection.
1.2.1.1 Toll-like receptors (TLRs)
TLRs are transmembrane proteins that serve as membrane-bound PRRs. There are 10
TLR family members encoded by the human genome and 12 by the mouse genome. TLR3,
TLR7, TLR8, and TLR9 detect viral nucleic acids in endosomal compartments. Except for
TLR9, which recognizes CpG-rich regions of viral DNA, the other TLRs, TLR3, TRL7, and
TL8, are of importance in sensing a flavivirus infection. The RNA ligands detected by the three
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flavivirus-activated TLRs differ. TLR3 recognizes double-stranded RNA (dsRNA) or a stemloop in a ssRNA; TLR7 and TLR8 recognize GU-rich ssRNA (Akira et al., 2006; Uematsu and
Akira, 2007).
TLR3 is expressed in immune cells as well as in non-immune cells, such as fibroblasts,
epithelial cells, and endothelial cells. Following ligand binding, TLR3 recruits the adaptor
molecule TIR domain-containing adaptor inducing IFN-β (TRIF) and signals through TNF
receptor-associated factor 3 (TRAF3) and TRAF6 to activate the kinase IκB kinase ε (IKKε) and
TANK-binding kinase 1 (TBK1), which activates the transcription factors IRF3, IRF7 and NFκB that trigger the transcription of IFN and pro-inflammatory cytokine genes (Akira et al., 2006;
Wang et al., 2011). The role of TLR3 in the innate immune response against a WNV infection is
complicated and controversial. In a study of WNV infections in TLR3-/- mice, two independent
research groups demonstrated distinct outcomes of a WNV infection (Wang et al., 2004; Daffis
et al., 2008). One study showed that TLR3-/- mice were more resistant to WNV infection
suggesting that impaired TLR3-dependent pro-inflammatory cytokine production leads to
increased penetration of the blood brain barrier and higher incidence of lethal infection (Wang et
al., 2004). The other study found that TLR3-/- mice were more susceptible to WNV infection as
evidenced by increased viral burdens in the brain, suggesting that TLR3 contributes to restrict
the viral infection and replication in neurons (Daffis et al., 2008). Interestingly, there is no
difference in the IFN levels produced between WNV-infected TLR3-/- and wild-type fibroblasts,
dendritic cells, or mice (Daffis et al., 2008), indicating that TLR3 is dispensable for IFN
induction in response to a WNV infection, and different PRRs are responsible for the induction
of IFN after WNV infection. The results from a study of human susceptibility to WNV infection
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suggested that higher levels of TLR3 in macrophages from aged donors leads to elevated levels
of pro-inflammatory cytokines and increased central nervous system disease (Kong et al., 2008).
The expression of TLR7 and TLR8 is mainly restricted to dendritic cells, macrophages,
and B cells. TLR7 and TLR8 transmit signals through the adaptor molecule myeloid
differentiation primary response gene 88 (MyD88), activating IRF7 and NF-κB, which activate
the expression of IFNs and pro-inflammatory cytokines (Akira et al., 2006; Wang et al., 2011).
TLR7 and its adaptor molecule MyD88 play a protective role against WNV-induced encephalitis
in mice. TLR7-/- mice and Myd88-/- mice both showed increased susceptibility to lethal WNV
infection, which appears to be linked to increased viral burden in the brain (Town et al., 2009;
Szretter et al., 2010). It is suggested that TLR7 and MyD88 provide protection against a WNV
infection by reducing immune cell migration to infected cell target sites. However, after WNV
infection, MyD88-/- mice showed a reduced IFN response while TLR7-/- mice showed an
elevated level of IFN in the blood, suggesting that the activation of IFN production occurs
through cross talk between signal pathways downstream of multiple PRRs.
1.2.1.2 RIG-I like receptors (RLRs)
The cytosolic RNA sensors, RLRs, are considered to be key intracellular PRRs for the
detection of a flavivirus infection. RLRs family receptors, which include the retinoic acid
inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5, also known as
IFIH1) and laboratory of genetics and physiology-2 (LGP2, also known as DHX58), are
expressed in most cell types. All three RLRs contain a DExD/H helicase domain and a Cterminal domain, which are both essential for binding viral RNA. In addition, RIG-I and MDA5
have two N-terminal caspase activation and recruitment domains (CARDs), which are proteinprotein interaction domains that are required for mediating antiviral signaling downstream of
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RNA recognition (Wilkins and Gale, 2010). In contrast, LGP2 lacks both CARDs and the
signaling effector domain and has been suggested to function as a regulator of RIG-I and MDA5;
however, its mode of action could be positive or negative regulation (Satoh et al., 2010; Wang et
al., 2011; Bruns and Horvath, 2012; Malur et al., 2012).
In the cytoplasm of a virus infected cell, the recognition of viral RNA activates the
enzymatic functions of RIG-I and MDA5 and initiates signal transduction pathways via the
adaptor protein mitochondrial antiviral signaling (MAVS), which is also called IPS-1, VISA, or
Cardif, localizing at the mitochondria, mitochondria-associated membranes (MAMs) and
peroxisomes (Barral et al., 2009; Gack, 2014). The activation of RIG-I or MDA5 and their
subsequent transportation to IPS-1 are tightly controlled by an interplay of ubiquitination and
phosphorylation modifications (Gack, 2014). IPS-1 transduces signaling that activates
transcription factors such as NF-κB, IRF3, IRF7, and ATF2/c-Jun, resulting in the production of
antiviral IFNs for the establishment of a broadly effective cellular antiviral state.
RLRs recognize pathogen patterns that are highly specific to viral RNAs and distinct
from host 5′-capped mRNA. Although RIG-I and MDA5 are structurally similar, they have
distinct ligand preferences that enable them to recognize the RNAs of different viruses. Early
studies suggested that the viral pathogens detected by RIG-I and MDA5 were non-overlapping.
However, new evidence suggests that both of RIG-I and MDA5 contribute to efficient detection
of VSV, Sendai virus, DENV and WNV infections (Wilkins and Gale, 2010; Gack, 2014). A
significant amount of research has been focused on understanding the molecular signatures that
are required for recognition by RLRs. Results from experiments with synthetic or purified viral
RNAs showed that RIG-I recognizes ssRNA with a 5′-triphosphate or short blunt-end dsRNA to
distinguish non-self from self RNA (Kell and Gale, 2015). The 5′-triphosphate moiety that
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stimulates RIG-I could be from the viral RNAs produced during replication or the RNA of
incoming virions (Weber et al., 2013). In addition, particular sequence compositions of the RNA
ligand play a role in RIG-I recognition. The poly-U/UC motifs in HCV genomic RNA activate
RIG-I in combination with a 5′-triphosphate moiety (Saito et al., 2008). In contrast, the
characteristics of MDA5 RNA ligands have not yet been well defined. The current thought is that
MDA5 recognizes long dsRNA (greater than 1 kb in length) and synthesized RNAs, such as poly
(I:C). Recognition by MDA5 does not require a 5′-triphosphalation on RNA (Schlee, 2013).
In the context of detecting a WNV infection, RLR signaling is crucial for activating the
innate and adaptive immune responses. Moreover, the roles of RIG-I and MDA5 are essential
and non-redundant in detecting WNV infection. Studies with WNV-infected RIG-I or MDA5
knockout cells showed that at early times of infection, RIG-I is activated to contribute to innate
immune protection, while at later times, MDA5 sustains and amplifies the antiviral response.
IPS-1 was indispensable for the RIG-I and MDA5 downstream signaling that controls WNV
infection (Fredericksen et al., 2008; Errett et al., 2013). Both RIG-I-/- and MDA5-/- mice
showed increased mortality after WNV challenge and double knock out RIG-I-/- /MDA5-/- mice
developed severe pathogenesis after WNV infection, similar to what was observed in IPS-1-/mice (Suthar et al., 2010; Errett et al., 2013). Additional studies showed that the exposed 5′
triphosphate and dsRNA structure activating RIG-I and MDA5 were produced during WNV
genome replication rather than those present on the incoming virion RNA (Shipley et al., 2012;
Errett et al., 2013). LGP2 is not essential for inducing an innate immune response to a WNV
infection. The elevated susceptibility of LGP2-/- mice to WNV infection is linked to a defect in
T cell expansion, which is not virus specific (Suthar et al., 2012). A study of WNV-infected IPS1-/- cells and mice suggested that the RLR signaling is not only important for inducing an innate
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immune response but also plays a role in regulating inflammation and modulating the adaptive
immune response (Suthar et al., 2010).
1.2.1.3 cGAS-STING-dependent sensors
cGAS (cyclic GAMP-AMP synthase) is a cytosolic DNA sensing enzyme. cGAS is
known to be triggered by DNA viruses and activates the production of IFN through stimulator of
interferon genes (STING, also known as MITA, MPYS or ERIS) and downstream IRF3 (Barber,
2015). STING, which was also shown to transduce signaling downstream of RIG-I, is associated
with the ER. cGAS-STING signaling was recently shown to be able to restrict DENV and WNV
infections, which is surprising because cGAS is a DNA-sensing PRR (Gack and Diamond,
2016). Ectopically expressed cGAS restricts WNV replication in human cells. In cGAS-/- cells,
WNV replicates to a higher level compared to WT control cells and cGAS-/- mice exhibited
elevated susceptibility to lethal WNV infection (Schoggins et al., 2014). The mechanism by
which cGAS protects the host from a WNV infection seems to be through maintaining a basal
immune response. Consistent with characteristics of the cGAS-/- mice, STING-/- mice are more
susceptible to lethal WNV infection (You et al., 2013). The cGAS-STING induced immune
response is effective against DNA viruses and only some of positive-sense single-stranded RNA
viruses, but how it is activated during an RNA virus infection has not yet been elucidated.
Possible ligands for cGAS activation in cells infected with a positive-sense, single-stranded RNA
virus infection include viral genome RNA, cDNA, dsRNA, and host cell-derived DNA. It was
suggested that STING could be activated by virus-induced ER membrane remodeling or by
fragments of mitochondrial DNA released from focal areas of virus-induced mitochondrial
fragmentation (Holm et al., 2012; Maringer and Fernandez-Sesma, 2014).
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1.2.2 IFNs
The expression of IFN genes in response to a stimulus is tightly controlled by some genespecific transcription repressors and sequence-specific transcription factors, which is the main
controlling level of IFN production (Levy et al., 2011). To date, three types of IFNs have been
identified. Type I IFNs, which include IFN-α, IFN-β, IFN-ε, IFN-κ, and IFN-ω, are secreted by
almost all cell types in mammals. Each of the type I IFNs is encoded by a single gene except for
IFN-α of which there are 13 subtypes in humans. Type I IFNs interact with the type I IFN
receptor (IFNAR) that is composed of the IFNAR1/IFNAR2 heterodimer on the cell surface.
Nearly every cell type expresses receptors for type I IFNs (Takaoka and Yanai, 2006; Maher et
al., 2007). Type II IFN, which includes only one species, IFN-γ, is produced by activated T
lymphocytes, monocytes, and NK cells, and binds to the IFN- γ receptor (IFNGR) composed of
an IFNGR1/IFNGR2 heterodimer (Takaoka and Yanai, 2006). IFN- γ plays a crucial role in
bridging the innate and adaptive responses (Schroder et al., 2004). Type III IFNs, which include
IFN-λ1 (IL-29), IFN-λ2 (IL-28A), IFN-λ3 (IL-28B), and IFN-λ4, bind to the IFN-λ receptor
composed of IFNLR1/IL-10Rβ (Fox et al., 2009; Levy et al., 2011). Expression of the IFN-λ
receptor is not well characterized with respect to cell type. It was originally thought to be limited
primarily to epithelial cells. Later studies demonstrated that hepatocytes express IFNLR1 and
respond to IFN-λ treatment (Sommereyns et al., 2008; Muir et al., 2010).
1.2.3 IFN signaling: The JAK-STAT pathway
The binding of IFN to receptors located on both infected and adjacent uninfected cells
activates the JAK kinases that are associated with the cell surface IFN receptors, leading to the
JAK-STAT pathway signaling that activates ISG expression. Four mammalian JAKs were
discovered: JAK1, JAK2, JAK3, and TYK2. In the absence of a stimulus, the JAK proteins are
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in an inactivate conformation. After type I IFN binding to the IFNAR1/2 heterodimer, the
JAK1/TYK2 kinases become activated and phosphorylate STAT1 and STAT2 on specific
tyrosines. The phosphorylated STATs interact with IRF9 to form the transcription factor
complex ISGF3 that translocates into the nucleus and binds to the ISRE of ISG promoters to
activate their expression (Takaoka and Yanai, 2006; Borden et al., 2007; Wilkins and Gale,
2010; Stark and Darnell, 2012). Type III IFN also activates JAK1 and TYK2 to activate the
formation of ISGF3 to induce ISG expression. However, type II IFN activates JAK1 and JAK2,
which activate tyrosine phosphorylation and dimerization of STAT1 that induces the expression
of ISGs through the gamma-activated sequence (GAS) promoter element. The STAT1
homodimer responding to type II IFN is also called gamma-activated factor (GAF) (Borden et
al., 2007).
The JAK-STAT pathway was defined in the 1990s. The trimeric ISGF3 complex is an
essential component of JAK-STAT signaling activated by type I and type III IFN. It was
subsequently discovered that in addition to the canonical ISGF3 complex with both STAT1 and
STAT2 tyrosine phosphorylated, there are another two forms of ISGF3 with transcription factor
function. In one, only STAT1 is tyrosine phosphorylated and binds to non-phosphorylated
STAT2 and IRF9, which forms in response to IFN-γ (Morrow et al., 2011). The other is nonphosphorylated STAT1 and STAT2 binding to IRF9, which forms in response to type I IFNs to
prolong the expression of a subset of ISGs (Cheon and Stark, 2009; Stark and Darnell, 2012). All
three forms of ISGF3 can bind to the ISRE (Fink and Grandvaux, 2013; Majoros et al., 2017).
The versatile functions of STAT1 are tightly regulated by its post-translational modifications.
Besides tyrosine phosphorylation, phosphorylation of STAT1 on serine 708 induced by IKKε
can regulate the expression of some ISGs (Tenoever et al., 2007; Perwitasari et al., 2011).
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Moreover, this serine phosphorylation inhibits the homodimerization of STAT1 but does not
disrupt ISGF3 formation, thus distinguishing type II IFN signaling activation from type I and
type III IFN (Ng et al., 2011). During the early stages of ISG induction, STAT1 is tyrosine
phosphorylated, but unphosphorylated STAT1 functions during the late stages of ISG expression
prolongation after virus infection (Levy and Darnell, 2002; Stark and Darnell, 2012).
The mammalian STAT protein family consists of 7 members: STAT1, STAT2, STAT3,
STAT4, STAT5A, STAT5B, and STAT6. They are expressed in different tissues and respond to
various cytokines. For example, STAT6 is mainly distributed in bone-marrow-derived cells;
STAT3 gets tyrosine phosphorylated in response to IL-6, while STAT1 and STAT2 respond to
IFNs (Aaronson and Horvath, 2002; Cheon et al., 2011). In addition to the well-studied ISGF3
complex and STAT1 dimer, increasing numbers of reports suggest that additional STAT proteins
play a role in the IFN response. Some other STAT containing complexes, including a STAT3
homodimer, a STAT5 homodimer, a STAT2/STAT1 heterodimer, and a STAT5/CRKL
heterodimer, can be induced by IFNs to mediate gene transcription (Brierley and Fish, 2005). In
response to different subtypes of type I IFNs, different human leukocyte subsets employ
signaling mediated by different STAT proteins, suggesting a cell-type specificity of the IFN
response. In addition, the cell-type specific responses to type I IFNs might be activated by
several different kinases besides JAKs, including PI3K and p38 kinase (van Boxel-Dezaire et al.,
2006; van Boxel-Dezaire et al., 2010).
1.2.4 The IFN response elements of ISG promoters
The two major DNA regulatory elements, ISRE and GAS, on the promoters of ISGs have
been shown to mediate the gene expression as a result of the activation of the JAK-STAT
pathway.
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1.2.4.1 ISRE consensus
The ISRE, with the consensus sequence 5′-A/GNGAAANNGAAACT-3′ (Darnell et al.,
1994), is the DNA motif that the trimeric factor ISGF3 complex, which is composed of STAT1,
STAT2, and IRF9, binds to in response to type I and type III IFN binding to their cell surface
receptors. The binding of the ISGF3 complex to the ISRE site leads to expression of ISGs
required for the innate antiviral immune response. The exact DNA binding contacts of the ISGF3
complex are not known, as no co-crystal structure of ISGF3-ISRE has been solved.
Recent studies suggested some non-canonical proteins can bind to the ISRE downstream
of type I IFN binding to its receptor. An ISGF3-like complex containing STAT6, STAT2 and
IRF9 was observed binding to the ISRE element in type I IFN-stimulated B cells (Gupta et al.,
1999; Fink and Grandvaux, 2013). In the absence of STAT1, STAT2 and IRF9 alone can form a
complex that binds to the ISRE sequence to regulate the expression of some ISGs and establish
an antiviral response to DENV infection (Kraus et al., 2003). Similar STAT1-independent
resistance has been reported against other kinds of virus infections (Perry et al., 2011; Blaszczyk
et al., 2015; Majoros et al., 2017).
The consensus sequence of the ISRE partially overlaps that of the IRF-binding elements
(IRF-E) which have the consensus sequence 5′-AANNGAAANNGAAA-3′. The IRF-E site is
recognized by proteins from the IRF family (Fujii et al., 1999; Taniguchi et al., 2001). The exact
nucleotide sequence of the binding site for each IRF family member is slightly different. Studies
show that besides ISGF3, IRF7 can bind to the ISRE and regulate ISG expression. ISREs can be
grouped into IRF7-specific, ISGF3-specific, and universal ISREs (Schmid et al., 2010).
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1.2.4.2 GAS consensus
The GAS site, with the canonical consensus sequence 5′-TTCNNNGAAA-3′, is the DNA
motif that the STAT1 homodimer binds to in response to type II IFN (Aaronson and Horvath,
2002). Recent studies have reported that some other STAT complexes can recognize GAS-like
elements after type I IFN treatment. A STAT2 homodimer can modulate expression of a subset
of ISGs through binding to a GAS-like site with a palindromic sequence of TTNNNNAA in
response to type I IFN; a STAT1/STAT2 heterodimer can bind to another GAS-like site with the
consensus sequence ATTCCCNGAAA, which is found in the promoter of IRF1 (Ghislain et al.,
2001; Brierley et al., 2006). The binding affinity between a STAT dimer and a DNA sequence is
determined by the nucleotide sequence as well as by cooperative interactions between the STAT
dimer and adjacent proteins on the promoter (Aaronson and Horvath, 2002).
1.2.5 The antiviral functions of ISGs
ISGs are a diverse group of hundreds of genes, whose expression establishes an antiviral
state in infected cells. Each type of IFN induces a different set of ISGs, and these sets of ISGs
partially overlap (Der et al., 1998). The ISGs can inhibit almost every step of a virus life cycle in
the host cells, including virus entry, translation, viral genome replication and transcription, viral
particle assembly and escape (de Veer et al., 2001; Schneider et al., 2014). The antiviral
functions of some of the proteins encoded by ISGs have been studied in recent years using a
siRNA library screen to knock down or a vector to overexpress single ISG. A number of ISGs
were found to have antiviral functions against influenza viruses, flaviviruses or alphaviruses
(Itsui et al., 2006; Zhang et al., 2007; Jiang et al., 2008; Brass et al., 2009; Brehin et al., 2009;
Jiang et al., 2010). Proteins encoded by ISGs known to have antiviral functions include dsRNAactivated protein kinase (PKR), MX1, 2′-5′ oligoadenylate synthetase (OAS1 and OAS3),
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ISG15, ISG20, IFITM-1, -2 and -3, and viperin (also known as RSAD2). A screen of more than
380 ISGs against six viruses confirmed the antiviral functions of IFITM, OAS, ISG15, ISG20,
viperin, MX, and IRF7 proteins, and identified additional antiviral proteins encoded by ISGs,
including interferon-induced proteins with tetratricopeptide repeats (IFIT) proteins and IRF1.
Most of the ISGs that have direct antiviral functions show antiviral activities against a wide
range of viruses (Schoggins et al., 2011). Among the >300 known ISGs, some are components of
the IFN induction and JAK-STAT pathways, such as RIG-I, MDA5, IRF7, IRF9, and STAT1.
However, the functions of the majority of the >300 ISGs have still not been fully described. It is
suggested that the combined functions of multiple ISGs increase the magnitude of the antiviral
activity (Schoggins and Rice, 2011; Schneider et al., 2014). However, a small subset of ISGs
was shown to be able to enhance the replication of a particular virus species, indicating the
complexity of the IFN system (Schoggins and Rice, 2011).
1.2.5.1 OAS family
Once an OAS protein is activated by double-stranded RNA, it catalyzes the formation of
unique 2′-5′ linked oligoadenylates from ATP, which serve as second messengers for the
dimerization and activation of endonuclease RNase L. Activated RNase L degrades both cellular
and viral ssRNA (Silverman, 2007). Expression of the OAS gene is activated by IFN signaling
and regulated by the ISRE in the OAS gene promoter (Rutherford et al., 1988). Moreover, the
OAS-RNase L system is an important IFN-induced antiviral pathway for several types of viruses,
including flaviviruses, picornaviruses, alphaviruses, and herpesviruses (Austin et al., 2005;
Silverman, 2007; Brehin et al., 2009; Hornung et al., 2014).
The human OAS family contains four genes: OAS1, OAS2, OAS3, and OAS-like
(OASL). The OAS1, OAS2, OAS3 proteins all have the 2′-5′ oligoadenylate synthase activity,
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whereas the OASL protein provides antiviral activity by enhancing the activation of RIG-I
signaling (Zhu et al., 2014). In contrast, the mouse OAS family contains eight Oas1 genes
(Oas1a to Oas1h), one Oas2, one Oas3, and two Oasl genes (Oasl1 and Oasl2) (Justesen et al.,
2000). The mouse Oas1 isoforms were generated by gene duplication (Perelygin et al., 2006).
Among the eight mouse Oas1 proteins, only Oas1a and Oas1g have been reported to have OAS
enzymatic activity (Kakuta et al., 2002). The non-enzymatic Oas1b has a specific antiviral
activity against members of the genus Flavivirus that is independent of the OAS/RNase L
pathway (Scherbik et al., 2007a; Elbahesh et al., 2011). Oas1d, which also encodes a nonenzymatic OAS protein, was reported to be involved in germline development (Yan et al., 2005).
The mouse Oas12 has OAS enzymatic activity, but Oasl1 does not (Eskildsen et al., 2003).
Mouse Oas1l has been shown to negatively regulate the production of type I IFN by inhibiting
the translation of IRF7, the transcription factor that positively regulates the expression of IFN
genes (Lee et al., 2013).
1.2.5.2 IFIT family
Interferon-induced proteins with tetratricopeptide repeats (IFIT) are highly induced by
type I or type III IFN treatment or by a viral infection. Proteins of the IFIT family, which have
no known enzymatic activities, inhibit viral replication in host cells through binding to viral
RNA together with other host proteins, and decrease virus transcription and translation (Fensterl
and Sen, 2015).
The human IFIT family consists of four members: IFIT1 (ISG56), IFIT2 (ISG54), IFIT3
(ISG60 or IFIT4), and IFIT5 (ISG58). The genes encoding human IFIT proteins are clustered
together on chromosome 10. A human pseudogene IFIT1B has been identified on human
chromosome 13, but it remains uncharacterized (Diamond, 2014). The mouse Ifit family consists

18

of three characterized members: Ifit1 (Isg56), Ifit2 (Isg54), and Ifit3 (Isg49). The murine Ifit
genes are clustered on chromosome 19qC1. The same locus also contains three additional
uncharacterized members: Ifit1b, Ifit1c, and Ifit3b (Fensterl and Sen, 2015). All human and
mouse IFIT genes, except for human IFIT1B, have one or two ISREs within 200 bp upstream of
the transcription start site, which drives their stimulus-dependent expression (Fensterl and Sen,
2011).
Antiviral functions have been demonstrated for several IFIT proteins. IFIT proteins
localize in the cytoplasm and inhibit cellular translation initiation by interaction with eIF3, which
is a large protein complex consisting of 13 different subunits termed eIF3a-m (Damoc et al.,
2007). In human cells, IFIT1 and IFIT2 both bind to the eIF3e subunit, and IFIT2 additionally
binds to eIF3c; in mouse, Ifit1 and Ifit2 selectively bind to eIF3c subunit. The binding of IFIT
proteins to eIF3 subunits prevents the formation of the preinitiation complex 48S (Hui et al.,
2005; Terenzi et al., 2005; Terenzi et al., 2006). IFIT proteins block viral protein translation as
well as cell protein translation in infected cells.
Mammalian cellular mRNAs contain a 5′ N-7 methylated guanosine cap linked by a 5′to-5′ triphosphate bridge to the first base, the ribose of which is further modified by methylation
at the 2′-O position (Decroly et al., 2011). These modifications assist in translational control as
well as in distinguishing self from non-self RNA. Both human IFIT1 and mouse Ifit1 recognize
2′-O unmethylated RNA and 5′-ppp RNA as non-self RNA. IFIT1 recognizes viral RNAs with
these types of 5′ ends and acts as an effector molecule to suppress viral translation. The full
antiviral function after IFIT1 binding to 5′-ppp RNA requires the binding of IFIT2 and IFIT3 to
IFIT1 (Pichlmair et al., 2011; Diamond, 2014). Human IFIT5 also binds to 5′-ppp RNA, but it is
not in the same complex with IFIT1, IFIT2, and IFIT3. The exact antiviral function of IFIT5 is
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not clear, but the protein was shown to co-localize with the cellular cytosolic sensor RIG-I
(Katibah et al., 2013; Vladimer et al., 2014).
Besides binding to host proteins and viral nucleic acids, IFIT1 protein has been
demonstrated to directly bind to a viral protein E1, which is a viral helicase encoded by human
papillomavirus (HPV) (a double-stranded DNA virus). The binding of IFIT1 to E1 sequesters
this viral helicase in the cytoplasm thus preventing it from aiding viral replication within the
nucleus (Terenzi et al., 2008).
1.2.5.3 IRF family
The interferon regulatory factor (IRF) family consists of nine members in mammals:
IRF1, IRF2, IRF3, IRF4 (also known as PIP or ICSAT), IRF5, IRF6, IRF7, IRF8 (also known as
ICSBP), and IRF9 (also known as ISGF3γ) (Taniguchi et al., 2001). IRF proteins do not have
direct antiviral activities, but most of them function as transcription factors for type I IFN
pathway genes. All of the IRF proteins have an N-terminal helix-turn-helix DNA-binding
domain (Ikushima et al., 2013). The DNA sequence that IRFs bind to is called the IRF binding
element (IRF-E) with the sequence 5′-AANNGAAANNGAAA-3′, which is recognized by all of
the IRF proteins, from IRF1 to IRF9 (Paun and Pitha, 2007). However, each IRF protein
possesses slightly different DNA binding specificities within the IRF consensus sequence
(Schmid et al., 2010). IRF4 and IRF8 are mainly expressed in lymphocytes, macrophages, B
cells and dendritic cells while the other IRFs are more ubiquitously expressed in almost all cell
types (Paun and Pitha, 2007).
IRF1, which was the first IRF protein discovered, has a prominent antiviral role against
numerous viruses, including WNV, YFV, human immunodeficiency virus (HIV) and
chikungunya virus (CHIKV) (Schoggins et al., 2011). IRF1 enhances the expression of the IFN-
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β gene but its precise role is not clear (Escalante et al., 1998). IRF1 was also shown to induce the
expression of many ISGs in the absence of IFN (Pine, 1992). Overexpression of IRF1 in human
STAT1-/- MEFs transcriptionally activates a set of ISGs without inducing the expression of IFN
(Schoggins et al., 2011). Therefore, IRF1 appears to activate an antiviral program in the absence
of STAT1 signaling and IFN gene induction.
IRF2 binds to the same DNA motif as IRF1, but it represses IRF1-induced transcriptional
activation (Hida et al., 2000). Moreover, it does not induce the expression of the IFN-α and IFNβ genes but acts as a negative regulator of the expression of type I IFNs as well as of IFN
signaling (Honda et al., 2004; Kuo and Calame, 2004).
IRF3 and IRF7 are the main transcription factors that induce the expression of type I
IFNs in virus-infected cells. IRF3 and IRF7, which are highly homologous, both have an Nterminal DNA binding domain and phosphorylation sites in the C-terminus that can be
phosphorylated in response to a virus infection (Taniguchi et al., 2001). IRF3 is constitutively
expressed and locates in the cytoplasm in a latent form. Upon viral infection, it is
phosphorylated, dimerizes, translocates to the nucleus and binds to its target DNA sequence on
the gene promoters switching on gene expression (Grandvaux et al., 2002; Mori et al., 2004).
Unlike IRF3, IRF7 is expressed at low levels in cells and its expression is upregulated by type I
IFNs. IRF7 regulates the expression of the IFN-α and IFN-β genes (Honda and Taniguchi, 2006).
Similar to IRF3, cytosolic IRF7 undergoes phosphorylation, dimerization and nuclear
translocation to become an active transcription factor. IRF3 and IRF7 can form homodimers and
heterodimers, and each of these dimers differently acts to regulate the expression of type I IFN
genes. An IRF3 homodimer and IRF3/IRF7 heterodimers regulate the early phase of IFN-β

21

production, while the IRF-7 homodimer appears to be responsible for maintaining the expression
levels of type I IFNs (Sato et al., 1998; Honda et al., 2005).
IRF5 has roles in the immune response to pathogens and apoptosis. It responds to TLR as
well as RLR signaling. The antiviral role of IRF5 is different from that of IRF7, mainly for the
set of genes it induces (Barnes et al., 2004). IRF5 is involved in the induction of some ISGs and
in IFN-β gene induction after WNV infection of dendritic cells (Lazear et al., 2013). In WNVinfected mice, IRF5 protects the host through shaping the early innate immune response, which
includes controlling the type I IFN responses and regulating the expression of other cytokines
and chemokines (Thackray et al., 2014). IRF6 is closely related to IRF5 with respect to amino
acid sequence, but it does not have an antiviral function. IRF6 is a key regulator controlling the
keratinocyte proliferation-differentiation switch (Richardson et al., 2006).
IRF9 is a component of the tertiary complex ISGF3 that is formed in response to type I
IFN binding to its receptor. It is essential for the antiviral response of type I IFN because it is the
major DNA-binding subunit of the transcription factor complex ISGF3, which also contains pSTAT1 and p-STAT2 (Taniguchi et al., 2001). IRF9 can also form ISGF3-like complexes with a
STAT1 homodimer or with STAT2 alone, which have similar DNA binding affinities as ISGF3
(Kraus et al., 2003).
1.3

Viruses antagonize the host IFN response at the cellular and molecular levels
Although the IFN response is critical for controlling virus infection, both RNA viruses

and DNA viruses have evolved multiple ways to invade the host IFN system. Viruses inhibit IFN
production, block the JAK-STAT signaling, or disrupt the action of ISGs.
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1.3.1 Virus infections that inhibit IFN production
Virus infections activate the host cell RLR-IPS-1 pathway, TLR-MyD88/TRIF pathway
or cGAS-STING pathway to induce the expression of type I IFNs. In the RLR-IPS-1 pathway,
the binding of viral RNA to cytosolic RLRs, mainly RIG-I and MDA5, causes a conformational
change in RIG-I and MDA5, which reveals the N-terminal CARD domain. In addition to a
conformational change, RIG-I and MDA5 undergo dephosphorylation by cellular
phosphoprotein phosphatase 1α (PP1α) and PP1γ before being released from the auto-repression
state. Lys63-linked ubiquitination by tripartite motif protein 25 (TRM25) and Riplet (also known
as RNF135 or REUL) is essential for RIG-I activation, while the requirement for Lys63-linked
ubiquitin chains for MDA5 activation is still being debated (Chiang et al., 2014). Active RIG-I
and MDA5 separately bind to IPS-1, which also has a CARD domain, through a CARD-CARD
interaction. This eventually leads to activation of IRF3, IRF7 (via IKKε and TBK1) and NF-κB
(via the IKKα/β/γ complex), which is required for the transcription of the IFN-β gene. The TLRMyD88/TRIF pathway and cGAS-STING pathway also ultimately lead to the activation of
IKKε, TBK1 and the IKKα/β/γ complex, thereby activating the transcription factors IRF3, IRF7
and NF-κB needed for induction of type I IFN gene expression. The induction of IFN signaling
can be divided into three phases: recognition of viral RNAs by PRRs, signaling transduction
from PRRs via adaptor proteins, and activation of the IRF and NF-κB transcription factors. Each
of these three phases can be a target for virus antagonism against IFN induction.
1.3.1.1 The counteraction to IFN production by non-flaviviruses
Both RNA viruses and DNA viruses encode proteins that can antagonize IFN production.
A well-characterized IFN antagonist is the influenza A virus non-structural protein NS1. This
protein blocks IFN induction through multiple mechanisms. NS1 binds to dsRNA via its N-
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terminal RNA-binding domain (RBD), thus potentially protecting viral RNA from detection by
cellular sensors (Donelan et al., 2003). In addition, NS1 binds to TRIM25 and Riplet to block
their mediation on Lys63-linked polyubiquitination of RIG-I (Gack et al., 2009). In the nucleus,
NS1 interacts with host protein CPSF30 via its C-terminal effector domain (ED), which results in
inhibition of host gene expression including the IFN genes (Garcia-Sastre, 2011).
Paramyxoviruses, which have single-stranded negative-sense RNA genome, have been
well studied for IFN production antagonism. The non-structural proteins V, W, and C, which are
produced from the single P/V/C gene through an RNA-editing mechanism, play important roles
in IFN antagonism (Goodbourn and Randall, 2009). Among them, V proteins are considered the
principal IFN antagonists. The V proteins have been shown to directly inhibit MDA5, to
indirectly inhibit RIG-I via LGP2, and also to inhibit the IRF3/IRF7 kinase IKKε and TBK1, to
prevent IFN gene expression. However, the inhibition mechanisms of the V proteins of different
members of this family are not the same (Andrejeva et al., 2004; Goodbourn and Randall, 2009;
Chiang et al., 2014; Hoffmann et al., 2015). The paramyxovirus W protein and C protein have
also been shown to inhibit the activation of IRF3 by mislocalizing the IRF3 protein inside the
nucleus (Shaw et al., 2005; Sparrer et al., 2012). DNA viruses encode specific proteins that
antagonize IFN production by targeting cGAS, nuclear translocation or the transcriptional
activity of IRF3 (Hoffmann et al., 2015).
1.3.1.2 The counteraction to IFN production by Flaviviruses
1.3.1.2.1 Prevention of recognition of viral components by PRRs
Flaviviruses have evolved ways to sequester or modify viral RNA to dampen recognition
by cell sensors. In infected cells, some of the small non-structural proteins of DENV and WNV
induce invaginations in the ER membrane that are the sites for exponential replication of genome
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RNA. These invaginations have been proposed to act as a physical barrier to conceal replicated
viral RNA from cellular cytosolic sensors (Welsch et al., 2009; Gillespie et al., 2010). Many
flaviviruses, including WNV, DENV, JEV, ZIKV, and YFV, add a 5′ cap structure to their
genomic RNAs, which is N7 and 2′-O methylated by the viral methyltransferases encoded in the
NS5 protein, thereby creating a mimic of the eukaryotic cell cap structures. Recombinant WNV,
JEV, and DENV with a mutation in the 2′-O-methyltransferase show growth attenuation in IFNcompetent cells (Daffis et al., 2010; Kimura et al., 2013; Li et al., 2013). A mutant WNV lacking
the 2′-O-methyltransferase was inhibited by murine Ifit1, but wild-type WNV was not. In
addition, the same mutant WNV was avirulent in wild-type mice but virulent in Ifit1-/- mice
(Daffis et al., 2010).
1.3.1.2.2 Inhibition of PRRs or their adaptor proteins
Lys63-linked polyubiquitination of RIG-I that is regulated by TRIM25 is required for
RIG-I activation. Host protein TRIM25 is a target of flavivirus sfRNA, which is a non-coding
RNA derived from the 3′UTR of the viral genomic RNA. The sfRNA of an epidemic DENV
strain was shown to bind to TRIM25, thus disrupting the stability of TRIM25 and weakening the
RIG-I mediated IFN response (Manokaran et al., 2015). The translocation of activated RIG-I to
interact with IPS-1, which is presented on mitochondria, mitochondria-associated membranes,
and peroxisomes, has been shown to be a target of flavivirus counteraction of IFN production.
The DENV and WNV NS3 proteins interact with a human cell protein, 14-3-3ε, which is the
chaperone for RIG-I translocation to mitochondria (Chan and Gack, 2016). The interaction
between NS3 and 14-3-3ε prevents the translocation of RIG-I to mitochondria; thus RIG-I cannot
interact with IPS-1(MAVs) to transduce downstream signaling.
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In the cGAS-STING pathway, STING transduces signaling downstream of the cell sensor
cGAS to activate the transcription factor IRF3. The DENV NS2B/3 protease cleaves human
STING, thus inhibiting cGAS mediated type I IFN induction. Murine STING is not a target of
DENV NS2B/3 because the cleavage site for DENV NS2B/3 is not present in the murine
ortholog (Aguirre et al., 2012; Yu et al., 2012a). WNV NS2B/3 has a structure very similar to
that of DENV NS2B/3, but WNV NS2B/3 shows more strict cleavage site specificities than
DENV NS2B/3 (Shiryaev et al., 2007). It is not known whether WNV NS2B/3 cleaves human
STING. Moreover, STING cleavage was not observed during JEV and YFV infection, which
was investigated with isolated JEV NS2B/3 protein or NS2B/3 protein of the YFV vaccine strain
17D (Yu et al., 2012b; Maringer and Fernandez-Sesma, 2014). Nevertheless, YFV NS4B is
known as an antagonist of STING since it binds and colocalizes with STING in transient
transfection experiments (Ishikawa et al., 2009).
WNV structural protein E has been shown to target the kinase, receptor-interacting
protein 1 (RIP1), which is downstream of TLR3-TRIF signaling for type I IFN induction. The
inhibition of RIP1 requires a particular glycosylation profile on the E protein. Only mosquito
cell-derived, but not mammalian cell-produced, WNV have this type of glycosylation profile on
E protein (Arjona et al., 2007).
1.3.1.2.3 Antagonism of signaling proteins and transcription factors downstream of PRRs
The kinases IKKε and TBK1 are required for activation of the transcription factors IRF3
and IRF7. DENV NS2B/3 protease binds to IKKε and blocks its kinase activity, thus inhibiting
IRF3 mediated IFN expression (Anglero-Rodriguez et al., 2014). Ectopically expressed DENV
NS2A and NS4B, as well as WNV NS4B (NY99 strain), inhibit the activation of TBK1 but the
exact mechanism involved is not known. The inhibition of TBK1 by NS2A and NS4B may
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require other factors because NS2A and NS4B do not directly interact with TBK1 (Dalrymple et
al., 2015). A study of NS2A from the WNV Kunjin strain demonstrated that a single amino acid
substitution (Ala30 to Pro) in this nonstructural protein controls its antagonism on IFN-β
promoter activity but the targeted cell protein is not known. Recombinant WNVKunjin with a
mutant NS2A had attenuated viral replication in cells and reduced virulence in mice (Liu et al.,
2004; Liu et al., 2006).
1.3.2

Viruses inhibit the IFN signaling pathway
Secreted type I IFNs bind to the IFNAR1/2 heterodimer receptor. The kinases that are

associated with the receptor, JAK1 and TYK2, then become activated through trans- and autophosphorylation and catalyze the phosphorylation of STAT1 and STAT2 which then form the
transcription factor complex ISGF3 with IRF9. The ISGF3 complex translocates into the
nucleus, binds to the ISRE in ISG promoters, and activates the expression of ISGs establishing
an antiviral state. Type III IFN activates the same kinases and transcription factor complex as
type I IFNs, while type II IFN activates JAK1 and JAK2 kinases and uses a p-STAT1 dimer as
the transcription factor (Schneider et al., 2014). Viruses have evolved several ways of interfering
with the IFN-induced JAK-STAT pathway to sustain high levels of infection. The viral
antagonizing strategies of the IFN signaling pathway fall into two major categories: inhibition of
kinase activities and direct targeting of STAT1 and/or STAT2.
1.3.2.1 The counteraction of the JAK-STAT pathway by non-flaviviruses
Paramyxovirus V proteins antagonize the JAK-STAT pathway through several different
mechanisms. Measles virus (MeV) V protein interacts with JAK1, which inhibits
phosphorylation of STAT1 and STAT2 (Caignard et al., 2007). V proteins of particular
paramyxoviruses (rubulaviruses) target STAT1 or STAT2 for proteasomal degradation. In
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rubulavirus-infected cells, a V-degradation complex (VDC) is formed, which contains the V
protein, STAT1, STAT2, and components of an E3 ubiquitin ligase complex. This VDC complex
mediates the polyubiquitination of the STAT proteins that results in their degradation. Although
both STAT1 and STAT2 are present in the VDC, only one of the two STAT proteins is
degraded, and which one is degraded differs among the viruses (Parisien et al., 2001; Andrejeva
et al., 2002; Hoffmann et al., 2015). Some other V proteins disrupt the JAK-STAT pathway by
sequestering STAT1 and STAT2 in the cytoplasm, thus preventing their nuclear translocation
and transcription factor function (Rodriguez et al., 2002; Rodriguez et al., 2003; Horvath, 2004).
The non-structural C proteins of the paramyxovirus, Sendai virus (SeV), have been found to bind
to STAT1 and STAT2 and interfere with STAT1 and STAT2 phosphorylation, while the C
protein of another paramyxovirus, human parainfluenza virus type 1 (hPIV1), binds to
phosphorylated STAT1 and sequesters it in cytoplasmic perinuclear aggregates (Komatsu et al.,
2002; Gotoh et al., 2003; Schomacker et al., 2012). Since STAT1 is involved in type I, II, III
IFN signaling, and STAT2 is involved in type I and III IFN signaling, the inhibition of both
STAT1 and STAT2 by paramyxovirus non-structural V and C proteins weakens type I, II, and III
IFNs signaling.
Another highly pathogenic virus, Ebola virus (EBOV), which belongs to the family
Filoviridae, can also interfere with IFN signaling. The VP24 protein of EBOV interacts with the
host karyopherin-α protein, which is a nuclear importer, and thus inhibits nuclear translocation of
phosphorylated STAT1 by this importer (Reid et al., 2006; Reid et al., 2007). However, the
VP24 protein of another highly pathogenic filovirus, Marburg virus (MARV), does not block
STAT1 nuclear import. Instead, the MARV VP40 protein acts as an antagonist against IFN
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signaling by preventing the function of JAK1 thus inhibiting the phosphorylation of STAT1 and
STAT2 (Basler and Amarasinghe, 2009; Valmas et al., 2010; Valmas and Basler, 2011).
1.3.2.2 The counteraction of the JAK-STAT pathway by flaviviruses
1.3.2.2.1 Inhibition of JAK1 or TYK2 activity
Non-structural protein NS4B of WNV is the antagonist that inhibits the activation of both
JAK1 and TYK2 in human cells, thereby blocking STAT activation (Keller et al., 2006; Evans
and Seeger, 2007). Both the DENV and YFV NS4B proteins function by blocking the activation
of STAT1 (Munoz-Jordan et al., 2005). In cells infected by JEV, the viral NS5 protein blocks
phosphorylation of TYK2 and STAT1 (Lin et al., 2006). WNV also blocks IFN signaling by
upregulating the expression of suppressors of cytokine signaling 1 (SOC1) and SOC3 that blunt
JAK1 activity. Another neuroinvasive flavivirus, TBEV, shares the same invasion strategy
against IFN signaling (Mansfield et al., 2010). Furthermore, WNV-induced depletion of
IFNAR1 dampens IFN signaling (Evans et al., 2011).
1.3.2.2.2 Direct targeting of STAT1 and STAT2
Flavivirus infections target STAT1 and STAT2 by directly blocking their
phosphorylation or by sequestering these STAT proteins in the cytoplasm or by targeting STATs
for degradation (Lin et al., 2006; Munoz-Jordan and Fredericksen, 2010). DENV NS5 targets
human STAT2 for proteasomal degradation but does not interact with murine STAT2 (Ashour et
al., 2010). In addition, ectopically expressed DENV NS5 binds to human STAT2, but not to
TYK2 or STAT1 and inhibits the phosphorylation of STAT2 (Mazzon et al., 2009). JEV NS5
blocks the phosphorylation of STAT1, thus inhibiting STAT1 nuclear translocation (Lin et al.,
2006). NS5 protein from WNV NY99 prevents the phosphorylation of STAT1 in human cells
(Laurent-Rolle et al., 2010). WNV Eg101 NS5 protein blocks phosphorylation of STAT proteins
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in primate cells, but in infected MEFs, STAT1 and STAT2 are phosphorylated, but their nuclear
translocation is blocked by an unknown mechanism (Pulit-Penaloza et al., 2012b). WNVinduced redistribution of cellular cholesterol was also shown to block STAT1 phosphorylation
and nuclear translocation, thus dampening IFN signaling (Mackenzie et al., 2007).
Studies of ZIKV from two different labs showed that ZIKV infection blocks the JAKSTAT pathway in host cells. The ZIKV NS5 protein targets human STAT2, which causes its
degradation, but it does not target mouse STAT2. This finding is similar to what was observed
for DENV NS5. However, unlike DENV NS5, ZIKV NS5-mediated STAT2 degradation does
not require the E3 ubiquitin ligase UBR4 (Grant et al., 2016). In A549 and human dendritic cells,
ZIKV infection inhibits the phosphorylation of STAT1 and STAT2 but the mechanism was not
studied (Bowen et al., 2017).
1.3.3 Virus escape of ISG antiviral functions
Although the functions of most of the ISGs are unknown, some proteins encoded by ISGs
have direct antiviral functions, for example, viperin and Ifit1, while some ISG proteins have
regulatory effects on the IFN system, for example, IRF3, IRF7, and STAT1. Viruses have
evolved ways to escape the antiviral functions of particular ISGs. One well-characterized
example is how viruses escape the antiviral function of Ifit1, which acts as a sensor of non-self
RNA as well as an antiviral effector. Flaviviruses use their own enzymes to generate a 5′ cap on
the viral genome to escape detection by Ifit1 as described previously. Alphavirus, which also has
positive-sense single-stranded RNA genome but no cap 1 structure, use a particular secondary
structure within the 5′ UTR of their genome RNA to alter Ifit1 binding and function, thereby
avoiding inhibition by Ifit1 protein (Hyde et al., 2014).
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GOAL OF THE DISSERTATION
Although WNV has the ability to inhibit the IFN signaling pathway, efficient
upregulation of a subset of ISGs, including Oas1a, Oas1b, and Irf7, was still observed in WNVinfected cells and cells deficient in IFN signaling (Pulit-Penaloza et al., 2012b). However, it was
not known which host cellular sensors were used to detect a WNV infection and signal the
initiation of this IFN-independent ISG upregulation mechanism. It was also not known which
transcription factors were involved in activating the ISGs or to which binding sites in the ISG
promoters these TFs bound. The goals of this study were to increase understanding of this noncanonical IFN-independent mechanism of ISG upregulation with studies designed to address the
following aims.

Aim 1. Analysis of the host cellular factors involved in the WNV-induced IFN-independent
ISG upregulation mechanism.
Aim 2. Functional analysis of the promoters of representative ISGs in WNV-infected MEFs
that do not respond to IFN.
The data obtained under Aims 1 and 2 are described in Chapter 2.
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2

IDENTIFICATION OF HOST CELLULAR FACTORS AND TRANSCRIPTION
FACTOR BINDING SITES INVOLVED IN A NON-CANONICAL INTERFERONSTIMULATED GENE UPREGULATION MECHANISM

2.1

Introduction
In response to a virus infection, host cells produce type I IFNs that serve as the first line

of antiviral defense. Secreted type I IFNs bind to their receptors, which are heterodimers of
IFNAR1 and IFNAR2, located on the surfaces of both infected and adjacent uninfected cells.
The binding of IFNs to their receptors activates the receptor-associated kinases inside the cells,
which phosphorylate STAT1 and STAT2. The transcription factor complex ISGF3 composed of
phosphorylated STAT1, phosphorylated STAT2 and interferon regulatory factor 9 (IRF9), forms
and translocates into the nucleus, binds to the IFN-stimulated response element (ISRE) in the
promoters of IFN-stimulated genes (ISGs) and activates ISG expression. The proteins encoded
by hundreds of ISGs target different steps of virus replication cycles, and their actions establish
an antiviral state.
Viruses have evolved various ways of evading the host IFN response by targeting either
IFN production or IFN signaling (Hoffmann et al., 2015; Gack and Diamond, 2016). In WNVinfected host cells, the induction, expression, and secretion of type I IFN occur normally, but the
canonical Janus tyrosine kinase (JAK)-STAT signaling pathway is blocked by the virus
infection. However, the Brinton lab previously discovered a backup antiviral response
characterized by the upregulation of a subset of ISGs when the canonical IFN-induced antiviral
signaling is blocked in WNV-infected mouse embryo fibroblasts (MEFs) (Scherbik et al.,
2007b). This subset of ISGs includes Oas1a, Oas1b, and Irf7. Each of these ISGs has a known
antiviral function. Oas1a, which is an enzymatically active synthetase, can synthesize 2′-5′
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oligoadenylates (2-5A) from ATP and 2-5A activates the latent endonuclease RNase L, leading
to RNase L-mediated cellular and viral RNA degradation (Scherbik et al., 2006; Silverman,
2007). Oas1b, which is an inactive synthetase, has antiviral activity that specifically targets
members of the genus Flavivirus and is independent of the OAS/RNase L pathway (Scherbik et
al., 2007a; Elbahesh et al., 2011). Irf7 is a “master regulator” that is an important regulator of the
production of type I IFNs after virus infection (Honda et al., 2005). The IFN independence of the
upregulation of a subset of ISGs was confirmed in WNV-infected Ifnar1-/- MEFs as well as in
WNV-infected STAT1-/- MEFs and STAT2-/- MEFs (Pulit-Penaloza et al., 2012b). These
results showed that the IFN-independent ISG upregulation mechanism still occurs in response to
a WNV infection when canonical IFN-dependent signaling is blocked. However, the finding that
the level of virus replication in Ifnar1-/- MEFs is higher than in wild-type MEFs indicates that
the broader IFN-induced canonical ISG response provides a more robust antiviral response
against WNV infection than the non-canonical upregulation of a subset of ISGs. Recent studies
suggest that the IFN-independent ISG upregulation mechanism is not limited to WNV-infected
MEFs. Influenza A virus was demonstrated to induce a set of ISGs in the absence of ISGF3
activation, suggesting that an IFN-independent ISG upregulation mechanism exists in influenza
A virus-infected cells (Schmid et al., 2010). A study screening over 380 ISGs for their antiviral
functions in a transient gene overexpression system showed that some ISG proteins could trigger
an antiviral program in human STAT1-/- fibroblasts (Schoggins et al., 2011). This result
suggests that an IFN-independent ISG upregulation mechanism also exists in human cells.
Although the IFN-independent ISG upregulation mechanism is a backup antiviral response,
further study of this mechanism is expected to broaden knowledge of host antiviral mechanisms
and to provide insights for future research in the host-virus interaction field.
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Several recent studies suggest that some ISGs can be upregulated in response to a virus
infection through pathways that are independent of the JAK-STAT signaling pathway
(Kalvakolanu, 2003; Schmid et al., 2010; Schoggins et al., 2011). A hypothesized mechanism of
alternative ISG upregulation is the activation of cell pathogen pattern receptors (PRRs) by viral
components activates signaling pathways, ultimately leading to the activation of transcription
factors and the induction of ISG expression. The cell cytosolic RNA sensors, RIG-I and MDA5,
can detect a WNV infection (Suthar et al., 2013; Lazear and Diamond, 2015). Signaling from
RIG-I or MDA5 is transduced through the downstream adaptor IPS-1. However, the Brinton lab
previously showed that in cells with RIG-I or MDA5 knocked out, IFN-independent ISG
upregulation still occurs (Pulit-Penaloza et al., 2012b). In contrast, when IPS-1 was knocked out,
ISGs were upregulated at 8 h post infection with WNV, but the mRNA levels decreased
progressively at later times, suggesting that IPS-1 is required for the IFN-independent
mechanism at later times after WNV infection when the viral proteins have inhibited canonical
IFN signaling (Pulit-Penaloza et al., 2012b). Transcription factors IRF3 or IRF7 can induce an
IFN-like transcriptome response in the absence of type I IFN signaling (Schmid et al., 2010).
However, IFN-independent ISG upregulation still occurred in WNV-infected IRF3-/-, IRF7-/and IRF3/7-/- MEFs indicating that IRF3 and IRF7 are dispensable for the IFN-independent ISG
upregulation mechanism (Pulit-Penaloza et al., 2012b). These results suggest that the alternative
IFN-independent ISG upregulation mechanism is working through cell sensors, but how this
mechanism regulates ISG expression is not fully understood.
In the present study, Mx1 and Ifit1 were identified as additional members of the subset of
ISGs that can be upregulated by WNV infection in an IFN-independent manner. The cellular
cytosolic sensors, RIG-I and MDA5, were found to be redundantly involved in detection of
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WNV infection that leads to the activation of the IFN-independent upregulation of ISGs. The
transcription factors IRF3, IRF5, and IRF7, were redundantly involved in mediating the
alternative upregulation of ISGs. A dual-luciferase assay system was established to map critical
DNA regulatory elements in the promoters of ISGs upregulated by the IFN-independent ISG
upregulation mechanism. By mapping the promoters of two representative ISGs, Ifit1 and Oas1b,
the ISRE, which is the regulatory element that mediates ISG upregulation in the canonical JAKSTAT pathway, was also found to be involved in mediating IFN-independent ISG upregulation
after WNV infection in mouse cells by interacting with a new protein complex. This novel ISREbinding transcription factor complex appears to contain NF-κB components, IRF3, IRF5 or
IRF7, and additional protein factors. The promoter regions flanking the ISRE also contribute to
the regulation of ISG expression in the IFN-independent mechanism.
2.2

Materials and methods

2.2.1 Cells and viruses
Primary IFNAR-/- (Ifnar1-/-), IRF1-/-, RIG-I/MDA5-/-, IRF5-/-, IRF3/5/7-/- and wildtype C57BL/6 MEFs (provided by Michael Diamond, Washington University School of
Medicine, St. Louis, MO) were cultured in high glucose Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, 1% non-essential
amino acid (NEAA), and penicillin (100 U/ml)/streptomycin (100 µg/ml). Primary MEFs were
used for experiments between passage 3 and passage 7. IFNAR-/- and wild-type C57BL/6 MEF
cell lines transformed by the 3T3 protocol were grown in DMEM supplemented with 3% FBS,
5% newborn bovine serum, 1% L-glutamine, and penicillin (100 U/ml)/streptomycin (100
µg/ml). tSTAT1-/- and wild-type t129/SvEv MEF cell lines (provided by Karen Mossman,
McMaster University, Hamilton, Ontario, Canada) were cultured in MEM supplemented with
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10% FBS, 1% L-glutamine and penicillin (100 U/ml)/streptomycin (100 µg/ml). These cells
were maintained at 37℃in an incubator in a 5% CO2 atmosphere.
A WNV Eg101 virus stock was prepared by infecting baby hamster kidney (BHK) cells
at a multiplicity of infection (MOI) of 0.1 and harvesting culture fluid at about 40 hours post
infection (hpi). The culture fluid was clarified by centrifugation at 2,000 rpm for 5 min, aliquoted
and stored at -80℃. A stock of WNV W956IC was made by transfecting in vitro transcribed
W956IC RNA into BHK cells (1 µg/2 × 106 cells) with the transfection reagent DMRIE-C
according to the manufacturer’s protocol (Invitrogen) (Basu and Brinton, 2011). At 72 h after
transfection, a time when BHK cells were rounded up but still attached, cell culture fluid was
harvested, clarified, aliquoted and stored at -80℃. Virus titers were assessed by plaque assay on
BHK monolayers as previously described (Emara et al., 2008).
2.2.2 Extraction of total cell RNA and quantification of cellular mRNAs
MEFs were cultured in 6-well plates and infected with WNV at the indicated MOI. At the
indicated times, cell lysates were collected with TRI-reagent (Molecular Research Center), and
total RNA was extracted following the manufacturer’s protocol. The purity and integrity of the
RNA were determined using a NanoVue Plus spectrophotometer (GE Healthcare) (at A260/A280
and A260/A230) and by RNA gel electrophoresis. One-step real-time quantitative (q) RT-PCR was
performed using the TaqMan RNA-to-Ct 1-step Kit (ThermoFisher Scientific) for each target
gene and the endogenous control gene in a singleplex format with 300 ng of total RNA. The
following TaqMan gene expression assays (20 × primer and FAM/MGB probe mixes) were
used: Mn00836412_m1 for Oas1a, Mn00449297_m1 for Oas1b, Mn00516793_m1 for Irf7,
Mm00515153_m1 for Ifit1, Mm00487796_m1 for Mx1, Mm00488995_m1 for Mx2,
Mm00491265_m1 for Rsad2 (Applied Biosystems). Glyceraldehyde-3-phosphate dehydrogenase
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(GAPDH) mRNA was detected as an endogenous control for each sample with mouse GAPDH
primers and probe (Applied Biosystems). The cycling reactions were run on an Applied
Biosystems 7500-Fast Real-time PCR System with the following parameters: reverse
transcription at 48°C for 15 min, AmpliTaq activation at 95°C for 10 min, denaturation at 95°C
for 15 sec, and annealing/extension at 60°C for 1 min (cycle repeated 40 times). Each experiment
was repeated at least twice and all samples were analyzed in triplicate. Triplicate threshold cycle
(Ct) values were used to calculate comparative fold change for the expression of the targeted
gene using the 2-∆∆Ct method provided by Applied Biosystems software. To estimate gene
induction by WNV infection, the transcript level obtained for each gene was normalized to the
GAPDH transcript level in the same sample and the relative fold change (RQU) was calculated
over the 8 h mock-infected sample. For the type I IFN treatment samples, the RQU was
calculated over the untreated sample value.
2.2.3 Plasmid construction and site-directed mutagenesis
2.2.3.1 Ifit1 promoter mapping constructs
The mouse Ifit1 gene promoter region analyzed consisted of sequence 1,000 bp upstream
and 66 bp downstream from the transcription start site (TSS). This region was amplified from
C57BL/6 genomic DNA using primers designed based on the C57BL/6J mouse genomic
sequence [(NCBI) Genbank ID: NC_000085.6]. The amplified PCR product was then cloned
into a Topo vector (Invitrogen) and sequenced. After digesting the Topo vector DNA with SacI
and HindIII, the insert fragment was subcloned into the Nanoluc (Nluc) luciferase reporter vector
pNL4.17 to generate the (-1000, +66) reporter construct. Additional Ifit1 promoter truncation
constructs were made using the Topo-Ifit1 promoter vector as a template and the primers listed
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in Table 2-1. Each of the PCR products was digested with SacI and HindIII and then ligated into
the Nluc luciferase reporter. All of the constructs were sequenced for verification.
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Table 2.1 Primer sequences used for construction of Ifit1 promoter fragments of different lengths
Ifit1-1000, +66

Forward primers
CTCAAGAGCTCTGAGCCCCACTGTCTGTAGTTCa

Reverse primers
CTCACAAGCTTGAACTCCTCAGAAACCTGCCTTb

Ifit1 -700, +66

CTCAAGAGCTCCATGACTATGATTGGTGGAAAG

CTCACAAGCTTGAACTCCTCAGAAACCTGCCTT

Ifit1 -500, +66

CTCAAGAGCTCGACACACAACAAACCAGCTAG

CTCACAAGCTTGAACTCCTCAGAAACCTGCCTT

Ifit1 -350, +66

CTCAAGAGCTCGCTTGGAAGAAAGAACAACAC

CTCACAAGCTTGAACTCCTCAGAAACCTGCCTT

Ifit1 -192, +66

CTCAAGAGCTCTGTATCCGTTTCAGAGCCTTC

CTCACAAGCTTGAACTCCTCAGAAACCTGCCTT

Ifit1 -132, +66

CTCAAGAGCTCCCACAGTGCGTCTCCCTG

CTCACAAGCTTGAACTCCTCAGAAACCTGCCTT

Ifit1 -50, +66

CTCAAGAGCTCCTGACTGAAAAGAGCACACC

CTCACAAGCTTGAACTCCTCAGAAACCTGCCTT

a
b

Underlined letters indicate the SacI restriction site included in all forward primers.
Underlined letters indicate the HindIII restriction site included in all reverse primers.

39

2.2.3.2 Oas1b promoter mapping constructs
Six Oas1b truncation promoter constructs were previously made by inserting promoter
fragments of various lengths into the pGL-4.17 firefly luciferase reporter plasmid DNA (PulitPenaloza et al., 2012b). These constructs were modified by replacing the reporter gene with the
Nluc luciferase gene using HindIII/BamHI sites. The Nluc gene was amplified from pNL1.1
CMV-Nluc DNA with the forward primer 5′-GCCAAGCTTGGCAATCCG-3′ and the reverse
primer 5′-CGACGGATCCTTATCG-3′ containing HindIII and BamHI restriction digest sites,
respectively (the restriction sites are underlined in the primer sequences). A promoter-less Nluc
luciferase reporter vector pNL-4.17 plasmid was also made using the same strategy for replacing
the firefly luciferase gene in the pGL-4.17 plasmid with the Nluc luciferase gene. Additional
Oas1b promoter fragments of different lengths were amplified by PCR with the primers listed in
Table 2-2 using the longest Oas1b promoter construct as a template. Internal deletion fragments
were made using a “double-joint PCR” strategy (Kim et al., 2009). For the fragment (-299/-202,
-93/+50) that has an internal deletion, two sub fragments were amplified with the primer pairs (299,-202) and (-93, +50)-1 respectively in the first-round PCR with the longest Oas1b promoter
construct used as a template, and then the two amplified sub fragments (ratio of 1:1) were fused
together in a second-round PCR. The fused product was then amplified with the primer pair (299/-202, -93/+50) in the third-round PCR. The other fragment (-299/-144, -93/+50) was
generated using the same strategy with primer pairs (-299, -144) and (-93, +50)-2 in the firstround PCR and primer pair (-299/-144, -93/+50) in the third-round PCR. The amplified promoter
fragments were next inserted into the pNL-4.17 plasmid at NheI/BglII sites. All of the constructs
were sequenced for verification.
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Table 2.2 Primer sequences used for construction of Oas1b promoter fragments of different lengths
Forward primer

Reverse primer
a

GAAGATCTCCTCTGCAGCCAGCAGb

(-299, +50)

CTAGCTAGCAGGAGATGGAAGCCGAGCTC

(-251, +50)

CTAGCTAGCCCTGATTCCGTTTCCCTTC

GAAGATCTCCTCTGCAGCCAGCAG

(-134, +50)

CTAGCTAGCCCTGGGCCGGATCTTAAG

GAAGATCTCCTCTGCAGCCAGCAG

(-93, +50)

CTAGCTAGCGTACCTGTTCAGAAGCCCTAAC

GAAGATCTCCTCTGCAGCCAGCAG

(-54, +50)

CTAGCTAGCCCTGGATGATTTGCATATC

GAAGATCTCCTCTGCAGCCAGCAG

(-28, +50)

CTAGCTAGCTTCCCGGGAAATGGAAACTG

GAAGATCTCCTCTGCAGCCAGCAG

(-299, -202)

CTAGCTAGCAGGAGATGGAAGCCG

CAGGTACTACGTTTTAGGAACAATCTGTGc

(-93, +50)-1

CTAAAACGTAGTACCTGTTCAGAAGCC

GAAGATCTCCTCTGCAGCCAGCAG

(-299/-202, -93/+50)

CTAGCTAGCAGGAGATGGAAGCCG

GAAGATCTCCTCTGCAGCCAGCAG

(-299, -144)

CTAGCTAGCAGGAGATGGAAGCCG

GTAAGGAAACTGACCTGGCTTTCTCG

(-93, +50)-2

GTTTCCTTACGTACCTGTTCAGAAGCC

GAAGATCTCCTCTGCAGCCAGCAG

(-299/-144, -93/+50)

CTAGCTAGCAGGAGATGGAAGCCG

GAAGATCTCCTCTGCAGCCAGCAG

a

Underlined letters indicate the NheI restriction site included in all forward primers.
Underlined letters indicate the BglII restriction site included in all reverse primers.
c
Double underlined letters indicate a linker sequence to connect the two sub fragments in the internal deletion promoter fragment.
b
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2.2.3.3 Site-directed mutagenesis of ISREs
The software tool MatInspector (Genomatix) was used to predict transcription factor
binding sites (TFBSs) in the Oas1b and Ifit1 promoter fragment sequences, and two ISREs were
identified in each gene promoter within 350 bp upstream of TSS. Specific mutations were
introduced into each of the ISREs of the Oas1b promoter constructs (-251, +50) and (-93, +50),
as well as into those of the Ifit1 promoter construct (-192, +66). Mutations were introduced using
the primers listed in Table 2-3 and a QuickChange II Site Directed Mutagenesis Kit (Agilent
Technologies) following the manufacturer’s protocol. The mutant construct sequences were
analyzed with MatInspector to ensure that the substitutions disrupted the ISRE but did not create
any new transcription factor binding sites. All of the constructs were verified by DNA
sequencing.
Table 2.3 Primer sequences used for ISRE motif mutation
Promoter sequence
Oas1b mISRE1
Oas1b mISRE2
Ifit1 mISRE1
Ifit1 mISRE2
a
b

a

F
R
F
R

GTGCACGTAGAAGAAGGGTACCGGAATCAGGAAACCACAb
TGTGGTTTCCTGATTCCGGTACCCTTCTTCTACGTGCAC
CAGAAATGGGACTTTCAGGTACCATTTCCCGGGAAGGGC
GCCCTTCCCGGGAAATGGTACCTGAAAGTCCCATTTCTG

F
R
F
R

GGATAAACTGCAGGCTTCAGGTACACTTTCCAGTCTCAGTTTC
GAAACTGAGACTGGAAAGTGTACCTGAAGCCTGCAGTTTATCC
GTACACTTTCCAGTCTCAGGTACAGTTTCTCACTGCTGACT
AGTCAGCAGTGAGAAACTGTACCTGAGACTGGAAAGTGTAC

F, forward primer; R, reverse primer.
Underlined letters indicate mutated nts.

2.2.4 Transient transfection and dual luciferase assay
In the study of mapping the promoters of Ifit1 and Oas1b, IFNAR-/- MEFs were seeded
at 6 × 104 cells/well in 24-well plates. After 24 h, cells were mock-infected or infected with
WNV W956 at a MOI of 3 and cultured with the antibiotic-free medium. At 3 hpi, 0.4 µg Oas1b
or Ifit1 promoter Nluc luciferase construct DNA was co-transfected with 0.1 µg firefly luciferase
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vector pGL 4.53 DNA (Promega) using Lipofectamine LTX with PLUS (Invitrogen) according
to the manufacturer’s protocol. At 28 hpi, cells were harvested with 150 µl Passive Lysis Buffer
(Promega) per well. The Nanoluc and firefly luciferase activities were measured separately with
the Dual-Glo® luciferase assay system (Promega) according to the manufacturer’s protocol
using a Victor 3 plate reader (Perkin Elmer). The Nanoluc luciferase activity was normalized to
the firefly luciferase activity in each sample.
In the study of investigating ISRE activation in an IFN-independent manner, a luciferase
reporter containing three copies of the ISRE consensus sequence (Stratagene) was co-transfected
with the pGL-TK Renilla luciferase reporter at a ratio of 20:1 using Lipofectamine LTX with
PLUS (Invitrogen) into mock-infected and WNV-infected IFNAR-/- MEFs. Firefly and Renilla
luciferase activities were measured with the Dual-Luciferase® reporter assay system (Promega)
according to manufacturer’s protocol using the Victor 3 plate reader (Perkin Elmer). The firefly
luciferase activity was normalized to the Renilla luciferase activity in each sample.
2.2.5 Electrophoretic mobility shift assay (EMSA) and supershift assay
IFNAR-/- MEFs were infected with WNV W956 at a MOI of 3 or mock-infected. At 21
hpi, cells were lysed, and nuclear extracts were collected with a Nuclear Fraction Kit (Active
Motif). The forward and reverse strands of the double-stranded Ifit1 oligonucleotide DNA
probes listed in Table 2-4 were synthesized with a 3′-biotin label (Integrated DNA
Technologies). After being reconstituted, 50 pmol of each strand were mixed with TE buffer and
annealed using a thermocycler with the following parameters: 95°C for 5 min, 95°C (-1°C/cycle)
for 1 min (cycle repeated 47 times), and held at 4°C. Annealed probes were aliquoted and stored
at -20°C. The same probe without a 3′-biotin label was used for cold probe competition
experiments. Nuclear extracts (3 µg) prepared from IFNAR-/- MEFs that were either mock- or
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WNV-infected were incubated with 20 fmol of labeled DNA probe for 1 h at 22°C. The 20 µl
binding reactions also included 50 ng/µl herring sperm DNA (non-specific nucleotide
competitor), 2.5% glycerol and 0.05% NP-40. To ensure specific binding between the DNA
probe and the proteins in the nuclear extract, 0.2 to 4 pmol of the unlabeled probe was added to
the reaction for specific competition with the biotin-labeled probe. For supershift assays, nuclear
extracts (3 µg) were incubated with 2 to 10 µg of anti-RelA antibody (Santa Cruz Biotechnology,
Cat#sc-8008x) for 30 min at 4°C prior to adding the DNA probe into the reaction. After
incubation for 1 h at 22°C, 5× loading buffer (ThermoFisher Scientific) was added and the
samples were electrophoresed on a 6% native polyacrylamide gel (ThermoFisher Scientific).
Electrophoresis was stopped when the front dye had migrated to about ¾ of the way to the
bottom of the gel. The DNA-protein complexes that were separated on the native polyacrylamide
gel were then transferred to a positively charged nylon membrane (GE Healthcare), where the
labeled probe was detected using a Chemiluminescent Nucleic Acid Detection Kit
(ThermoFisher Scientific) and a LAS4000 CCD camera with high-resolution increment
exposure. For supershift assays, the band intensities were measured three times with different
parameters for band detection and background removal using ImageQuant TL software.
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Table 2.4 Ifit1 promoter probe sequences used for EMSA
Probe sequence
a

FT66F
FT66Rb
FTmutF
FTmutR
a

5′-GATGATAAACTGCAGGCTTCAGTTTCACTTTCCAGTCTCAGTTTCAGTTTCTCACTGCTGACTGAAAAG-3′ bio
5′-CTTTTCAGTCAGCAGTGAGAAACTGAAACTGAGACTGGAAAGTGAAACTGAAGCCTGCAGTTTATC-3′bio
5′-GATGATAAACTGCAGGCTTCAGGTACACTTTCCAGTCTCAGGTACAGTTTCTCACTGCTGACTGAAAAG-3′ bioc
5′-CTTTTCAGTCAGCAGTGAGAAACTGTACCTGAGACTGGAAAGTGTACCTGAAGCCTGCAGTTTATC-3′-bio

Forward strand.
Reverse strand.
c
Underlined letters indicate mutated nts.
b
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2.2.6 Inhibition of the NF-κB pathway
The NF-κB inhibitor, Caffeic Acid Phenethyl Ester (CAPE) (Santa Cruz Biotechnology),
was dissolved in DMSO to make a 25 mg/ml stock solution. The effect of CAPE on the
alternative ISG upregulation mechanism was assayed by the dual luciferase assay with the Ifit1 (192, +66) Nluc luciferase construct. CAPE was added to the cell culture medium to final
concentrations of 3, 5, 10, or 15 µg/ml right after virus absorption, while 0.05% DMSO
treatment was used as controls. Significant differences were determined with a one-way
ANOVA with multi-comparisons to the DMSO treatment sample and Tukey’s post hoc test.
2.2.7 Detection of proteins by Western blotting in nuclear fractions
Nuclear and cytoplasmic extracts were prepared from IFNAR-/- MEFs using a Nuclear
Fraction Kit (Active Motif) following the manufacturer’s protocol. The protein concentrations in
these fractions were measured using a BCA assay (ThermoFisher Scientific). Equivalent
amounts (45 µg) of nuclear and cytoplasmic samples were used for SDS-polyacrylamide gel
electrophoresis (PAGE). The separated proteins were electrophoretically transferred to a
nitrocellulose membrane. The membrane was blocked with Tris-buffered saline (TBS, pH 8)
containing 5% nonfat dried milk or 5% bovine serum albumin (BSA) and 0.1% Tween-20 for 1 h
at room temperature and then incubated with a primary antibody overnight at 4℃. The membrane
was then incubated with anti-rabbit or anti-mouse antibody conjugated with horseradish
peroxidase (HRP) (Cell Signaling Technology) for 1 h at room temperature, washed with TBS
containing 0.1% Tween-20, and processed for chemiluminescence using a SuperSignal West
Pico Substrate kit (Thermo Fisher Scientific). The primary antibodies used were: anti-alphatubulin (Cell Signaling Technology, Cat#3873) and anti-Histone H3 (Cell Signaling Technology,
Cat#4499), anti-p65 (RelA) (Santa Cruz Biotechnology, Cat#sc-8008x), anti-p50 (Cell Signaling
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Technology, Cat#12540), anti-IRF3 (Cell Signaling Technology, Cat#4302), anti-IRF5 (Cell
Signaling Technology, Cat#4950), and anti-IRF7 (Invitrogen, Cat#PA5-20280).

2.3

Results

2.3.1 Mx1 but not Mx2 expression is induced by WNV in an IFN-independent manner
To identify additional ISGs in the subset that is induced by WNV infection in an IFNindependent manner, the mRNA expression levels of ISGs with known antiviral functions were
analyzed in WNV-infected IFNAR-/- MEFs. Mx proteins have been shown to have
evolutionarily conserved antiviral activities towards several families of viruses, among which the
majority studied were negative-strand RNA viruses. The expression of Mx genes is typically
strictly dependent on type I and III IFNs (Verhelst et al., 2013). Two Mx proteins are encoded by
the human (MxA and MxB) as well as the mouse (Mx1 and Mx2) genomes. Human MxA is a
cytoplasmic protein. Polymorphisms in the human MxA gene have been associated with HCV
infection outcomes (Knapp et al., 2003; Garcia-Alvarez et al., 2017). Mouse Mx1 localizes to
the nucleus and inhibits viruses that replicate in the nucleus, such as influenza virus, whereas
mouse Mx2 is cytoplasmic and protects against viruses that replicate in the cytoplasm, such as
vesicular stomatitis virus (VSV) (Haller et al., 2007). Rsad2 (also known as cig5 and viperin) has
antiviral activity against a wide variety of viruses (Helbig and Beard, 2014). Rsad2 has been
shown to be induced by all three types of IFN, and its expression is tightly regulated by ISGF3
(Severa et al., 2006). However, infection with another flavivirus, Japanese encephalitis virus
(JEV), directly activates Rsad2 expression through activating the transcription factors IRF3 and
AP-1 (Chan et al., 2008). The induction of Rsad2 in an IRF-3 dependent but an IFN-independent
manner was observed in cells infected with an alphavirus, Chikungunya virus (CHIKV) (White
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et al., 2011). Mice lacking Rsad2 showed increased mortality after WNV infection (Szretter et
al., 2011).
The mRNA expression levels of Mx1, Mx2, and Rsad2 were measured by real-time
quantitative (q) RT-PCR in the total cellular RNA samples collected from WNV Eg101-infected
IFNAR-/- MEFs. At 34 hpi, Mx1 was upregulated in WNV Eg101-infected IFNAR-/- MEFs.
Neither Mx2 nor Rsad2, which are induced by IFN-β treatment in wild-type MEFs, were
detected in the WNV-infected IFNAR-/- MEFs (Figure 2-1 A). The IFN-independent induction
of Mx1 was next investigated in RNA samples of WNV Eg101-infected IFNAR-/- MEFs
collected at different times after infection. Mx1 mRNA expression was induced by WNV Eg101
infection of IFNAR-/- MEFs, and the peak transcript level was observed at 32 hpi (Figure 2-1 B).
The kinetics of Mx1 upregulation were similar to those of the other ISGs in this subset after
WNV Eg101 infection in IFNAR-/- MEFs (Pulit-Penaloza et al., 2012b). The data indicate that
Mx1 is another member in the subset of ISGs that can be induced by WNV in an IFNindependent manner. The data also confirmed that only a subset of ISGs could be induced by the
alternative mechanism.
The human MxA and mouse Mx1 proteins have antiviral activity against negative-strand
RNA viruses but are not very effective in inhibiting flaviviruses. The cytoplasmic human MxA
protein was reported to sequester WNV capsid protein that was ectopically expressed from a
vector, but this potential inhibitory effect on replication was not observed in the context of a
virus infection (Hoenen et al., 2014). Constitutive expression of murine Mx1 protein protects
against influenza virus infection but not WNV infection in mice (Moritoh et al., 2009).
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Figure 2.1 Mx1, but not Mx2 and Rsad2, is upregulated in an IFN-independent manner.
Primary IFNAR-/- MEFs and wild-type C57BL/6 MEFs were mock-infected or infected
with WNV Eg101 at a MOI of 5 for the indicated times, or treated with IFN-β (1000 U/ml) for 3
h. (A) Mx1, Mx2 and Rsad2 mRNA levels were measured by real-time qRT-PCR in cellular
RNA samples from mock- or WNV-infected IFNAR-/- MEFs collected at 34 hpi or from
control- or IFN-treated wild-type C57BL/6 MEFs (positive control). (B) The Mx1 mRNA levels
in IFNAR-/- or wild-type MEFs at different times after WNV infection were analyzed by realtime qRT-PCR. The transcript level of each gene was normalized to the GAPDH transcript level

49

in the same sample and is shown as the relative fold change over the amount in 34 h mockinfected samples. For the IFN-treated sample, the relative fold change was calculated over the
amount in an untreated MEF sample. Each sample was assayed in triplicate, and representative
data from one of three independent experiments are shown. The error bars represent standard
deviation (SD). CN, untreated control. Iβ, IFN-β treatment.
2.3.2 Ifit1 is an additional ISG in the subset that is induced by WNV infection in an IFNindependent manner
IFIT proteins (interferon-induced proteins with tetratricopeptide repeats) are known to be
induced by type I or type III IFN treatment or viral infection. IFIT proteins have no known
enzymatic activities but inhibit virus transcription and translation in host cells (Fensterl and Sen,
2015). The Ifit1 gene is conserved among mammals. Cytoplasmic Ifit1 protein recognizes nonself RNA structures, such as 2′-O unmethylated RNA and 5′-ppp RNA and acts as an effector
molecule to suppress viral translation (Pichlmair et al., 2011; Diamond, 2014). To escape the
antiviral function of Ifit1, flaviviruses have evolved their own capping machinery to modify the
5′ end of the viral RNA in the same way that host mRNA is modified. A WNV with a mutation
inhibiting the viral 2′-O-methyltransferase activity showed reduced pathogenesis in wild-type
mice due to the action of the Ifit1 protein (Szretter et al., 2012).
To determine whether Ifit1 can be induced by WNV infection in an IFN-independent
manner, the transcript level of Ifit1 was assayed in WNV Eg101-infected MEFs by real-time
qRT-PCR. After WNV infection, Ifit1 was highly induced in primary wild-type C57BL/6 MEFs
as well as in IFNAR-/- MEFs (Figure 2-2 A). The data indicate that Ifit1 can be induced by
WNV infection in an IFN-independent manner as well as in an IFN-dependent manner. IFNindependent induction of Ifit1 was also observed in WNV-infected tSTAT1-/- MEFs, which lack
a fundamental component of the JAK-STAT signaling pathway. The tSTAT1-/- MEFs and
control wild-type t129 MEFs used were transformed cell lines. As expected, Ifit1 gene
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expression was induced by WNV infection in both wild-type t129 and tSTAT1-/- MEFs (Figure
2-2 B). The data indicate that Ifit1 is also a member of the subset of ISGs that are induced by
WNV infection by an IFN-independent mechanism.

Figure 2.2 Ifit1 is upregulated in an IFN-independent manner by WNV infection.
Ifit1 mRNA expression was measured by qRT-PCR in WNV Eg101-infected (MOI of 5)
(A) primary IFNAR-/- MEFs and (B) transformed STAT1-/- MEFs. MEFs were mock-infected
or infected with WNV strain Eg101 at the indicated times post infection, or treated with IFN-β
(1000 U/ml) for 3 h. The Ifit1 transcript level was normalized to the transcript level of GAPDH
in the same sample and is shown as the relative fold change over the amount in the 8 h mockinfected samples. Each sample was assayed in triplicate, and representative data from one of
three independent experiments are shown. The error bars represent SD. CN, control. Iβ, IFN-β
treatment.
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2.3.3 Comparison of the alternative ISG upregulation mechanism induced by WNV Eg101
and WNV W956IC
WNV Eg101 was used in the initial study that discovered the IFN-independent
upregulation of ISGs after WNV infection (Pulit-Penaloza et al., 2012b). W956IC (referred as
W956 hereafter) is an engineered chimeric WNV. The majority of the W956 genome is from the
lineage II WNV strain B956, with the 1,496 nts from the 3′ end from the lineage I WNV strain
Eg101 (Yamshchikov et al., 2001). Compared to the natural virus strain Eg101, the chimeric
virus produces higher levels of “unprotected” viral RNA at early times after infection, which
activate the cellular RNA sensors inducing elevated levels of IFN-β. Because more RNA
replication than genome translation is occurring at early times after infection, fewer viral proteins
that inhibit the canonical IFN signaling are produced. Consequently, W956-infected cells rapidly
produce high levels of ISGs that reduce the yield of W956 virus in type I IFN-competent cells
(Scherbik et al., 2013). Therefore, it was hypothesized that a WNV W956 infection would
induce the IFN-independent expression of ISGs to a higher level than a WNV Eg101 infection.
To test this hypothesis, the extent of upregulation of some representative ISGs induced by
the IFN-independent mechanism by these two WNVs was compared. IFNAR-/- MEFs, which do
not have canonical IFN signaling, were infected with WNV W956 or WNV Eg101 at a MOI of
5. Total cellular RNA samples were collected from W956-infected cells at 8, 16, 24, 32 and 48
hpi. Total cellular RNAs were only collected at 8, 24 and 32 hpi after WNV Eg101 infection
because this was a repeat of previously published data.
Oas1a, Oas1b, and IRF7 mRNA expression level were analyzed by real-time qRT-PCR.
In response to WNV Eg101 infection, the transcription of Oas1a and Oas1b mRNA increased
since 8 hpi and reached a peak level of more than a 1000-fold change at 32 hpi in IFNAR-/-
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MEFs (Figure 2-3 A and B). Irf7 was induced by only about 100 fold at 32 hpi after WNV
Eg101 infection of IFNAR-/- MEFs (Figure 2-3 C). The WNV Eg101 data obtained are
consistent with previously published data (Pulit-Penaloza et al., 2012b).
In WNV W956-infected IFNAR-/- MEFs, high levels of Oas1a, Oas1b, and Irf7
expression levels were observed by 16 hpi, which were similar to the levels reached by 32 hpi in
WNV Eg101-infected cells. Although the expression levels of Oas1a and Oas1b progressively
decreased with time after infection starting at 24 hpi, the Irf7 levels did not decline (Figure 2-3 D
to F). These data demonstrate that WNV W956 induces more robust IFN-independent expression
of the subset of ISGs at early times after virus infection than WNV Eg101, which is likely due to
the strong activation of the cellular RNA sensors by the high levels of “unprotected” viral RNA
produced at early times in WNV W956-infected cells.
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Figure 2.3 WNV W956 induces the alternative mechanism of ISG expression to a higher level
than WNV Eg101 at early times after infection.
Transformed (3T3) IFNAR-/- and wild-type C57B/6 MEFs were infected with WNV
Eg101 or WNV W956 at a MOI of 5, and total cellular RNA was collected at the indicated times
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after infection. The mRNA expression levels of Oas1a, Oas1b, and Irf7 were measured by realtime qRT-PCR in WNV Eg101-infected MEFs (A to C) and WNV W956-infected MEFs (D to
F). The transcript level of each gene was normalized to the GAPDH transcript level in the same
sample and is shown as relative fold change over the amount in the 8 h mock-infected samples.
Each sample was assayed in triplicate. Representative data from one of three independent
experiments are shown. The error bars represent SD.

To compare the yields produced by WNV Eg101 and WNV W956 in IFN-incompetent
MEFs, IFNAR-/- MEFs were infected (MOI of 1), and the extracellular virus titers were
measured by plaque assay. At 12 hpi, WNV W956-infected IFNAR-/- MEFs produced 10 times
more virus than the WNV Eg101-infected cells. The virus yields were similar at 24 hpi and after
that were slightly lower from the W956-infected cells (Figure 2-4). The observation that higher
yields of W956 are produced at an early time after infection but not at later times was similar to
what was observed in BHK cells, which also have a defective IFN system (Scherbik et al., 2013).
Overall, these data suggest that in W956-infected IFN-incompetent cells, the “unprotected” viral
RNA produced at early times after infection (around 12 h) rapidly activates IFN-independent
antiviral signaling.
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Figure 2.4 Comparison of virus production by WNV Eg101 and W956 virus infections in IFNAR/- MEFs.
Confluent monolayers of 3T3-transformed IFNAR-/- MEFs were infected with WNV
Eg101 or WNV W956 at a MOI of 1. At the indicated times after infection, culture fluids were
collected, and infectivity was determined by plaque assay. The values are averages of duplicate
titrations of each sample from two independent biological repeats. The error bars represent SD
(n=4).

2.3.4 The alternative ISG upregulation mechanism is activated by viral RNA sensor RIG-I
or MDA5
The RLR family of cytosolic sensors, RIG-I and MDA5, are both essential for the
induction of IFN expression and control pathogenesis after a WNV infection (Errett et al., 2013).
After viral RNA binds to RIG-I or MDA5, signaling is transduced through the adaptor molecule
IPS-1 to activate downstream signaling leading to the induction of IFN-β gene expression. In
WNV-infected cells, the expression and secretion of type I IFN are normal, but signaling induced
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by secreted IFN binding to its cell surface receptor is blocked by viral nonstructural proteins. A
previous study in the Brinton lab showed that in MEFs lacking IPS-1, the IFN-independent
subset of ISGs is upregulated at 8 hpi but is progressively decreased thereafter (Pulit-Penaloza et
al., 2012b). These data suggest that IPS-1 is involved in regulating this subset of ISGs in the
IFN-independent manner. IPS-1 is the downstream adaptor molecule of RIG-I and MDA5. In
MEFs lacking either RIG-I or MDA5, the alternative ISG upregulation mechanism was still
observed in WNV Eg101-infected MEFs (Pulit-Penaloza et al., 2012b). However, the lack of
RIG-I resulted in a slight reduction in gene upregulation levels (Pulit-Penaloza et al., 2012b). It
was not known whether RIG-I and MDA5 redundantly sense WNV RNA or whether viral RNA
was detected by a different cell sensor during the induction of the IFN-independent upregulation
of ISGs. Toll-like receptor 3 (TLR3), TLR7, and TLR8 have been shown to be involved in
sensing a WNV infection (Gack and Diamond, 2016). The cyclic GAMP-AMP synthase (cGAS),
which senses DNA, was shown to be activated by both a WNV and a dengue virus (another
flavivirus) infection. cGAS signaling is transduced through stimulator of interferon genes
(STING) which can associate with IPS-1 (Ishikawa et al., 2009; Kell and Gale, 2015).
The characteristic of producing high levels of early viral RNAs that activate the cell
sensors makes WNV W956 a better virus than WNV Eg101 for studying the involvement of cell
sensors in the IFN-independent mechanism. MEFs lacking both RIG-I and MDA5 were used to
determine whether RIG-I and MDA5 function redundantly in sensing viral RNA during the
initiation of IFN-independent upregulation of ISGs. RIG-I-/-/MDA5-/- MEFs were infected with
WNV W956 at a MOI of 5 to ensure that all of the cells were infected and total cellular RNA
was harvested at the indicated times. ISG transcripts levels were assayed by real-time qRT-PCR.
In WNV W956-infected RIG-I-/-/MDA5-/- MEFs, Oas1a, Irf7, and Ifit1 were not upregulated
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after virus infection (Figure 2-5 A, C and D). Although a low-level induction of Oas1b was
detected after virus infection, the level was not significantly higher than that in the 24 h mockinfected sample (Figure 2-5 B). Because the previously published data on IFN-independent ISGs
in RIG-I-/- and MDA5-/- MEFs were obtained using WNV Eg101 (Pulit-Penaloza et al., 2012b),
the RIG-I-/-/MDA5-/- MEFs were also infected with WNV Eg101. A similar decrease in the
upregulation of the IFN-independent ISGs was observed in WNV Eg101-infected RIG-I-//MDA5-/- MEFs (data not shown) as with WNV W956 infection. The data indicate that either
RIG-I or MDA5 can activate the IFN-independent antiviral mechanism.
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Figure 2.5 At least one of the cytosolic sensors, RIG-I and MDA5, is needed for the induction of
the IFN-independent mechanism.
Primary RIG-I-/-/MDA5-/- MEFs and wild-type C57BL/6 MEFs were mock-infected or
infected with WNV W956 at a MOI of 5. The mRNA expression levels of (A) Oas1a, (B) Oas1b,
(C) Irf7, and (D) Ifit1 were measured by real-time qRT-PCR in total cellular RNA samples
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collected at the indicated hpi. The transcript level of each gene was normalized to the GAPDH
transcript level in the same sample and is shown as relative fold change over the amount in the 8
h mock-infected samples. Each sample was assayed in triplicate, and representative data from
one of three independent experiments are shown. The error bars represent SD.

2.3.5 Analysis of the involvement of IRF family transcription factors in the upregulation of
the IFN-independent subset of ISGs by a WNV infection
IRF family members were initially identified as transcription factors for genes in the type
I IFN pathway. There are nine well-conserved members in the mammalian IRF family: IRF1,
IRF2, IRF3, IRF4, IRF5, IRF6, IRF7, IRF8, and IRF9 (also known as ISGF3γ) (Taniguchi et al.,
2001). All of the IRF proteins have a helix-turn-helix DNA-binding motif (Ikushima et al.,
2013). The DNA binding site for all of the IRFs is called the IRF-binding element (IRF-E), and
its consensus sequence is 5′-AANNGAAANNGAAA-3′ (Paun and Pitha, 2007). However, each
IRF protein processes slightly different DNA binding specificities within the IRF-E consensus
sequence (Schmid et al., 2010).
IRF9 is expressed in a variety of tissues and is essential for the antiviral response induced
by type I IFN signaling because it is the DNA-binding subunit of the transcription factor
complex ISGF3 (Taniguchi et al., 2001). In a previous study in the Brinton lab, Oas1a and Oas1b
were shown to be upregulated in WNV-infected IRF3-/- MEFs but not in IRF3/9-/- MEFs,
suggesting the possibility that IRF9 is involved in the upregulation of ISGs by the IFNindependent mechanism (Pulit-Penaloza et al., 2012b). To analyze the role of IRF9 in
upregulating the expression of Oas1a, Oas1b, and Irf7 by an IFN-independent mechanism, the
transcript levels of these genes were analyzed in primary IRF9-/- MEFs at various times after
WNV infection. Oas1a, Oas1b and Irf7 were all induced in WNV-infected IRF9-/- MEFs (Figure
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2-6). The data indicate that IRF9 is not required for the upregulation of these ISGs in WNVinfected MEFs and that the IRF3/9-/- MEFs likely had an additional defect(s).

Figure 2.6 The IFN-independent subset of ISGs is upregulated in IRF9-/- MEFs after WNV
infection.
Primary IRF9-/- MEFs were mock-infected or infected with WNV Eg101 at a MOI of 5.
Cells incubated with IFN-β (1000 U/ml) for 3 h were used as a control. The mRNA expression
levels of Oas1a, Oas1b, and Irf7 were measured by real-time qRT-PCR in cellular RNA samples
collected at the indicated hpi. The transcript level of each gene was normalized to the GAPDH
transcript level in the same sample and is shown as relative fold change over the amount in the 8
h mock-infected samples. The level of Oas1a in 8 h mock-infected sample was too low to be
detected, so the amount in 16 h WNV-infected samples was used to calculate relative fold
change. Each sample was assayed in triplicate. Representative data from one of three
independent experiments are shown. The error bars represent SD.
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IRF1, the first discovered member of the IRF family, was shown to induce the expression
of many ISGs in the absence of IFN (Pine, 1992). The overexpression of IRF1 in human STAT1/- MEFs was subsequently shown to transcriptionally activate a subset of ISGs without inducing
the expression of IFN (Schoggins et al., 2011). The role of IRF1 in upregulating the expression
of the subset of ISGs activated in an IFN-independent manner by a WNV infection was next
analyzed. Primary IRF1-/- MEFs and matched wild-type MEFs were infected with WNV W956
at a MOI of 5, and total cellular RNA was collected at the indicated times. The transcript levels
of Oas1a, Oas1b, Irf7, and Ifit1 were measured by real-time qRT-PCR. Each of these four genes
was efficiently upregulated in IRF1-/- and control cells by both IFN-β and WNV infection
(Figure 2-8 A to D). The data suggest that IRF1 alone is not required for the upregulation of the
subset of IFN-independent ISGs in WNV-infected MEFs.
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Figure 2.7 The IFN-independent subset of ISGs is upregulated in IRF1-/- MEFsafter WNV
infection.
Primary IRF1-/- MEFs and the wild-type C57BL/6 MEFs were mock-infected or infected
with WNV W956 at a MOI of 5. Cells treated with IFN-β were used as positive controls. The
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mRNA expression levels of (A) Oas1a, (B) Oas1b, (C) Irf7, and (D) Ifit1 were measured by realtime qRT-PCR in cellular RNA samples collected at the indicated hpi. The transcript level for
each gene was normalized to the GAPDH transcript level in the same sample and is shown as
relative fold change over the amount in the 8 h mock-infected samples. The relative fold change
after IFN-β treatment was calculated over the amount in untreated cells. Each sample was
assayed in triplicate. Representative data from one of three independent experiments are shown.
The error bars represent SD. CN, untreated control. Iβ, IFN-β treatment.
IRF5 is involved in the signaling pathway downstream of the RIG-I/MDA5-IPS-1
pathway for type I IFN production (Ikushima et al., 2013). IRF5 has been reported to be
involved in the upregulation of some ISGs as well as in IFN-β gene induction after WNV
infection in dendritic cells (Lazear et al., 2013). In WNV-infected mice, IRF5 provided
protection through shaping the early innate immune response, which includes controlling the
type I IFN response and regulating the expression of other cytokines and chemokines (Thackray
et al., 2014). The role of IRF5 in upregulating the IFN-independent subset of ISGs was analyzed
in WNV-infected MEFs. Primary IRF5-/- MEFs and matched wild-type MEFs were infected
with WNV W956 at a MOI of 5, and total cellular RNA samples were collected at the indicated
times. The transcript levels of Oas1a, Oas1b, Irf7, and Ifit1 were assayed by real-time qRT-PCR.
All four genes were efficiently upregulated in IRF5-/- and control MEFs by both IFN-β and
WNV infection (Figure 2-9 A to D). The data suggest that the IFN-independent subset of ISGs
can be upregulated by WNV infection when IRF5 is absent.
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Figure 2.8 The IFN-independent subset of ISGs is upregulated in IRF5-/- MEFs after WNV
infection.
Primary IRF5-/- MEFs and wild-type C57BL/6 MEFs were mock-infected or infected
with WNV W956 at a MOI of 5. Cells treated with IFN-β for 3 h were used as a positive control.
The mRNA expression levels of (A) Oas1a, (B) Oas1b, (C) Irf7, and (D) Ifit1 were measured by
real-time qRT-PCR in total cellular RNA samples collected at the indicated times after infection.
The transcript level for each gene was normalized to the GAPDH transcript level in the same
sample and is shown as relative fold change over the amount in the 8 h mock-infected samples.
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The relative fold change after IFN-β treatment is calculated over the amount in control treatment.
Each sample was assayed in triplicate. Representative data from one of three independent
experiments are shown. The error bars represent SD. CN, untreated. Iβ, IFN-β treatment.

Among all the IRF family members, IRF3 and IRF7 are closely related to each other with
respect to their amino acid sequences. Both IRF3 and IRF7 have an N-terminal DNA binding
domain and some phosphorylation sites in the C-terminal region (Taniguchi et al., 2001). IRF3 is
constitutively expressed and located in the cytoplasm as a latent form. IRF7 is induced by type I
IFNs and further regulates the expression of IFN-β. Phosphorylation is required for nuclear
translocation and transcription factor activities of IRF3 and IRF7 (Honda and Taniguchi, 2006).
Previous data from the Brinton lab showed that Oas1a, Oas1b, and Irf7 are still upregulated in
WNV-infected IRF3-/-, IRF7-/- and IRF3/7-/- MEFs (Pulit-Penaloza et al., 2012b). A
comparative study of WNV-infected IRF3/7-/- and IRF3/5/7-/- dendritic cells suggested that
IRF5, IRF3 and IRF7 are responsible for the induction of IFN-β and some ISGs after virus
infection (Lazear et al., 2013).
The induction of Oas1a, Oas1b, and Ifit1 was analyzed in WNV-infected IRF3/5/7-/MEFs. These cells were infected with WNV Eg101 at a MOI of 5 for consistency with the
previous study in IRF3/7-/- MEFs. Oas1a, Oas1b, and Ifit1 mRNA expression levels were
induced by IFN-β treatment in the IRF3/5/7-/- MEFs. However, the induction of each of the
three genes by WNV infection was less than 10 fold by 8 hpi, and the induction decreased with
time (Figure 2-10 A to C). Expression of the IFN-β gene was not induced by WNV infection in
these cells, confirming that the IRF3/5/7-/- MEFs do not produce IFN-β in response to WNV
infection (Lazear et al., 2013) (Figure 2-10 D). The data suggest that IRF3, IRF5, or IRF7 can
function as transcription factors in the IFN-independent ISG upregulation by WNV infection,
and that they are functionally redundant.
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Figure 2.9 IRF3, IRF5, and IRF7 each can function in regulating the IFN-independent
mechanism.
Primary IRF3/5/7-/- MEFs and wild-type C57BL/6 MEFs were mock-infected or infected
with WNV Eg101 at a MOI of 5. Cells incubated with IFN-β (1000 U/ml) for 3 h were used as
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positive controls. The mRNA expression levels of (A) Oas1a, (B) Oas1b, (C) Ifit1, and (D) Ifnb1
were measured by real time qRT-PCR in total cellular RNA samples collected at the indicated
times after infection. The transcript level for each gene was normalized to the GAPDH transcript
level in the same sample and is shown as relative fold change over the amount in the 8 h mockinfected samples. The relative fold change after IFN-β treatment was calculated over the amount
in untreated cells. Each sample was assayed in triplicate. Representative data from one of three
independent experiments are shown. The error bars represent SD. CN, untreated control. Iβ, IFNβ treatment.

Ifit1 gene expression was previously reported to be upregulated through the transcription
factor IRF3 after activation of cell sensors by viral or bacterial components (Fensterl and Sen,
2011). To determine whether the IFN-independent upregulation of Ifit1 in WNV-infected cells is
IRF3-dependent as previously reported, Ifit1 mRNA expression levels in WNV-infected IRF3-/MEFs were analyzed by real-time qRT-PCR. Ifit1 was upregulated in both IRF3-/- and control
MEFs after infection with either WNV W956 or WNV Eg101. However, the induction by WNV
W956 reached a higher level at an earlier time after infection (Figure 2-11). The data
demonstrate that IRF3 alone does not control the IFN-independent upregulation of Ifit1 after
WNV infection.
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Figure 2.10 Ifit1 is induced by WNV infection in an IRF3-independent manner in MEFs.
Primary IRF3-/- and wild-type C57BL/6 MEFs were mock-infected or infected with
WNV W956 or WNV Eg101 at a MOI of 3 for indicated hpi. Ifit1 mRNA expression was
assessed by real-time qRT-PCR. The Ifit1 transcript level was normalized to the transcript level
of GAPDH in the same sample and is shown as relative fold change over the amount in the 18 h
mock-infected samples. Each sample was assayed in triplicate. Shown data are representative of
three independent biological repeats. Error bars represent SD.

2.3.6 Mapping alternative response elements in the Ifit1 promoter
As an alternative method for predicting putative transcription factors involved in the IFNindependent ISG upregulation mechanism, functionally important transcription factor binding
site (TFBS) regions in the promoters of representative ISGs were mapped. TFBSs are typically 6
to 12 bp in length, while the promoter of a gene is typically more than 1000 bp in length.
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Therefore, serially truncated promoter fragments were used for the initial mapping studies using
a dual luciferase assay system.
Because of its high level of induction in WNV-infected cells by the IFN-independent
mechanism, the Ifit1 gene promoter was chosen for mapping. The longest Ifit1 promoter
fragment containing 1000 bp upstream and 66 bp downstream of the transcription start site (TSS)
was first cloned into the Nluc luciferase reporter vector pNL4.17. IFNAR-/- MEFs were mockinfected or infected with WNV W956 at a MOI of 3. At 3 hpi, cells were co-transfected with
Ifit1 promoter Nluc luciferase construct DNA and a firefly luciferase vector DNA. Cell extracts
were harvested at 28 h after infection (25 h after transfection) and assayed for luciferase activity.
Basal luciferase activity, which was well distinguished from the background, was detected for
the longest Ifit1 (-1000, +66) construct in mock-infected cells. In WNV-infected cells, this
construct showed a significant increase in promoter activity, indicating that the promoter was
activated by the virus infection (Figure 2-11 A). A set of 5′ sequentially truncated Ifit1 promoter
fragments was next cloned into the Nluc luciferase reporter construct and assayed by the dual
luciferase assay system. Similar basal activities in mock-infected cells were detected for all of
the 5′ truncated promoters except the shortest Ifit1 promoter fragment (-50, +66), which had
lower basal activity (Figure 2-11 A). The lower activity of fragment (-50, +66) suggested that the
region from -132 to -50 contains elements that enhance basal Ifit1 expression. After WNV
infection, the promoter activities of all of the Ifit1 promoter constructs were highly induced.
Among them, expression from the longest promoter fragment Ifit1 (-1000, +66) was induced
more than 10 fold after the infection. The sequential 5′ truncation constructs Ifit1 (-700, +66) and
Ifit1 (-500, +66) showed decreased luciferase activity compared to Ifit1 (-1000, +66), suggesting
that the region from -1000 to -500 contains enhancers (Figure 2-11 A). However, the promoter
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activities of Ifit1 (-350, +66) and (-192, +66) were higher than that of Ifit1 (-500, +66),
indicating that the region from -500 to -192 negatively regulates the promoter activity after virus
infection through repressors contained in this region. The promoter activity of Ifit1 (-132, +66)
was about 65% of that of Ifit1 (-192, +66), suggesting that the region from -192 to -132 contains
enhancers. Comparison of the promoter activities of Ifit1 (-132, +66) and Ifit1 (-50, +66) showed
that the deletion of the promoter region from -132 to -50 decreased the promoter activity by
about 95%, suggesting that some very strong enhancers are contained in this region (Figure 2-11
A). The mapping data suggest that within the Ifit1 promoter, the regions from -1000 to -500, and
from -192 to -50 contain enhancers while the region from -500 to -192 contains repressors
(Figure 2-11 B). The promoter activity of the Ifit1 (-192, +66) construct corresponded to about
80% of the promoter activity of the longest Ifit1 promoter construct, which contains both an
enhancer region (A1) and a repressor region in the region from -1000 to -192 (Figure 2-11 A),
suggesting that the enhancer A1 region can overcome the repressor effects in regulating Ifit1
gene expression after WNV infection.
The ISRE is the TFBS to which the transcription factor complex ISGF3, which is
composed of p-STAT1, p-STAT2, and IRF9, binds during the canonical JAK-STAT pathway in
response to secreted type I IFNs binding to their cell surface receptors. There are three ISREs on
the Ifit1 promoter. One ISRE is located in the enhancer A1 region between -700 and -500. The
Ifit1 (-700, +66) construct, which contains this ISRE, showed higher luciferase activity than Ifit1
(-500, +66) construct that does not contain this ISRE (Figure 2-11 A). The other two ISREs on
the Ifit1 promoter are located in the enhancer region between -132 and -50. Both of the promoter
fragments Ifit1 (-192, +66) and Ifit1 (-132, +66), which contain the two ISREs, showed much
higher promoter activities than the Ifit1 (-50, +66) fragment, which does not contain any ISRE
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(Figure 2-11 A). The promoter mapping results suggested the possibility that the ISRE may
contribute to the increased promoter activity. However, although both promoter fragments Ifit1 (192, +66) and Ifit1 (-132, +66) contain two ISREs, the lower promoter activity of Ifit1 (-132,
+66) compared to that of (-192, +66) suggests that additional elements in the region from -192 to
-132 are also involved in upregulating the induction of Ifit1 gene expression in WNV-infected
IFNAR-/- MEFs (Figure 2-11 A).

Figure 2.11 Mapping the mouse Ifit1 gene promoter regions that are activated after WNV
infection by the IFN-independent mechanism.
Reporter vectors containing Ifit1 promoter fragments of different lengths were
constructed. (A) Diagram of the promoter fragments tested (left side) and their luciferase
activities (right side). Arrows indicate the position of the TSS. The upstream distances to the
TSS are indicated. All promoter fragments terminate 66 bp downstream of the TSS. Transformed
(3T3) IFNAR-/- MEFs were mock-infected or infected with WNV W956 at a MOI of 3. At 3
hpi, cells were co-transfected with a Nluc luciferase reporter construct DNA and firefly
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luciferase vector pGL4.53 DNA (transfection control) in triplicate. At 28 hpi, cell lysates were
prepared, and luciferase activity was measured. The Nluc luciferase activity was normalized to
the firefly luciferase activity for each sample. Error bars represent SD. Significant differences
were determined with a two-way ANOVA with multi-comparisons across the activities of
promoters of different lengths and Tukey’s post hoc test (*, p<0.05). (B) Diagram of the
regulatory regions of the Ifit1 promoter during an IFN-independent response. The upstream
distances to the TSS are indicated. A, enhancer. R, repressor.

2.3.7 Mapping alternative response elements in the Oas1b promoter
The promoter of mouse Oas1b was also mapped to locate cis-acting elements that
respond to IFN-independent signaling in WNV-infected cells using the dual luciferase assay
system. An Oas1b promoter fragment that contained 802 bp upstream and 50 bp downstream of
the TSS was cloned into the Nluc luciferase vector pNL4.17. A set of 5′ sequentially truncated
Oas1b promoter constructs was then made. IFNAR-/- MEFs were mock-infected or infected with
WNV W956 at a MOI of 3, and then co-transfected with each Oas1b promoter Nluc luciferase
construct DNA and a firefly luciferase vector DNA at 3 hpi. Cell extracts were harvested at 28
hpi (25 h after transfection), and luciferase activity was assayed. The basal activities of the
Oas1b constructs were slightly higher and more variable than those found for the Ifit1 promoter
constructs, with only the Oas1b (-54, +50) and Oas1b (-28, +50) constructs showing lower basal
activities that were still well distinguished from background. The construct Oas1b (-299, +50)
produced a higher basal activity than the other constructs that contained either longer or shorter
Oas1b promoter fragments. The observation that the basal activity of Oas1b (-28, +50) was 30fold lower than that of Oas1b (-299, +50) suggested that the region between -299 and -28
contains elements that enhance basal Oas1b expression in IFNAR-/- MEFs (Figure 2-12 A). All
of the Oas1b promoter constructs were activated by WNV infection with more than a 3-fold
induction. The construct Oas1b (-802, +50) showed higher promoter activity than the constructs
Oas1b (-742, +50) and Oas1b (-576, +50), suggesting that in Oas1b promoter, the region from -
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802 to -576 contains enhancers (Figure 2-12 A). The observation that the promoter activity of
Oas1b (-507, +50) was higher than that of Oas1b (-576, +50) suggested that the region between 576 and -507 contains repressors. The observed decrease in promoter activity between Oas1b (507, +50) and Oas1b (-394, +50) was subtle and demonstrated no statistical significance, but the
deletion of the region from -394 to -299 significantly increased promoter activity as indicated by
the promoter activities of constructs Oas1b (-394, +50) and Oas1b (-299, +50), suggesting the
region between -394 to -299 contains repressors. Moreover, the promoter activity of Oas1b (576, +50) was lower than that of Oas1b (-299, +50), indicating that the region between -576 and
-299 contains multiple strong negative regulatory elements (Figure 2-12 A). The construct Oas1b
(-299, +50) demonstrated the highest WNV-induced promoter activities among all the Oas1b
promoter constructs. Multiple 5′ deletions in the region from -299 to -28 decreased the promoter
activity, suggesting that this region contains enhancers (Figure 2-12 A). The mapping data
suggest that within the Oas1b promoter, the regions from -802 to -576, and from -299 to -28
contain enhancers while the region from -576 to -299 contains repressors (Figure 2-12 C).
The construct Oas1b (-299, +50) showed higher promoter activity than that of the longest
promoter construct Oas1b (-802, +50), suggesting that the promoter region in the Oas1b (-299,
+50) construct contains all of the key elements needed for IFN-independent upregulation of
Oas1b after WNV infection. This region was further mapped using constructs with additional 5′
deletions or internal deletions. Comparison of the promoter activities of Oas1b (-299, +50),
Oas1b (-251, +50) and Oas1b (-181, +50) demonstrated that deletion of the region between -251
and -181 significantly decreased promoter activity. In addition, each sequential 5′ deletion of the
region from -134 to -28 dramatically decreased the promoter activity as demonstrated by the
activities of the Oas1b (-134, +50), Oas1b (-93, +50) and Oas1b (-28, +50) fragments. However,
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the deletion of the region from -181 to -134 increased promoter activity as shown by constructs
Oas1b (-181, +50) and Oas1b (-134, +50). The data suggest that even in the enhancer region
from -299 to -28, there is still a subregion containing repressors. However, the repressors cannot
overcome the effect of enhancers in the adjacent subregions (Figure 2-12 B). Comparison of the
luciferase activities of the two constructs with internal deletions, Oas1b (-299/-202, -93/+50) and
(-299/-144, -93/+50), showed that adding the piece of promoter from -202 to -144 decreased
promoter activity, confirming the existence of repressor elements in the -181 to -144 region
(Figure 2-12 B). The mapping data suggest that in Oas1b promoter, the regions from -802 to 576, from -299 to -181, and from -134 to -28 contain enhancers while the regions from -576 to 299, and from -181 to -134 contain repressors (Figure 2-13 C). The results indicate that the
regulation of the Oas1b promoter is more complicated than that of the Ifit1 promoter in WNVinfected IFNAR-/- MEFs.
There are two ISREs in the Oas1b promoter. When the 5′ ISRE was deleted in the Oas1b
promoter [compare fragments (-251, +50) and (-181, +50)], the promoter activity decreased by
one-third (Figure 2-12 B), suggesting that this ISRE plays an important role in regulating the
IFN-independent induction of Oas1b by WNV infection. Although the shortest Oas1b promoter
(-28, +50) contains the 3′ ISRE, it had very low luciferase activity (Figure 2-12 B). The
sequential 5′ deletions from -134 to -28 dramatically decreased the promoter activity, suggesting
the possibility that enhancers in this region may cooperatively regulate Oas1b gene promoter
activation with the 3′ ISRE in WNV-infected IFNAR-/- MEFs.
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Figure 2.12 Mapping the mouse Oas1b gene promoter regions activated after WNV infection by
the IFN-independent mechanism.
Reporter constructs containing Oas1b promoter fragments of different lengths were
constructed. (A, B) Diagram of the promoter fragments tested (left side) and their luciferase
activities (right side). Arrows indicate the TSS. The upstream distances to the TSS are indicated.
All promoter fragments terminate 50 bp downstream of the TSS. Transformed (3T3) IFNAR-/-
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MEFs were mock-infected or infected with WNV W956 at a MOI of 3. At 3 hpi, cells were cotransfected with a Nluc luciferase reporter construct DNA and firefly luciferase vector pGL4.53
DNA (transfection control) in triplicate. At 28 hpi, cell lysates were prepared, and luciferase
activity was measured. The Nluc luciferase activity was normalized to firefly luciferase activity
for each sample. Error bars represent SD. Significant differences were determined with a twoway ANOVA with multi-comparisons across the activities of promoters of different lengths and
Tukey’s post hoc test (*, p<0.05). (C) Diagram of the regulatory regions of the Oas1b promoter.
The numbers indicate locations upstream of the TSS. A, enhancer. R, repressor.
2.3.8 ISRE motifs in the Ifit1 and Oas1b promoters are involved in the alternative gene
upregulation mechanism
The mapping data obtained for the Oas1b and Ifit1 promoters suggest the involvement of
an ISRE in regulating the non-canonical ISG upregulation mechanism. The consensus sequence
of the ISRE is 5′A/GNGAAANNGAAACT3′, where the 3′ GAAA (underlined) is the core
binding site (Darnell et al., 1994). Both the Ifit1 promoter (Figure 2-11 A) and the Oas1b
promoter (Figure 2-12 A and B) contain two ISREs within 350bp upstream of TSS. In the Ifit1
promoter, the two sites are located in the region between -132 and -50 and are separated by 19
nts. In the Oas1b promoter, one ISRE is located between -251 and -181 while the other is
between -28 and TSS (206 nts apart). Each of the ISREs in the Oas1b and Ifit1 promoters was
individually mutated to change the core binding consensus from GAAA to GTAC. The mutated
sequence was analyzed using MatInspector software to confirm that the ISREs had been
eliminated and no new TFBSs had been created. The promoter activity of each mutated construct
was analyzed.
The ISREs were mutated in the Ifit1 (-192, +66) construct. Mutation of either ISRE in the
Ifit1 promoter decreased the luciferase activity by more than 80% (Figure 2-13 A). When both of
the ISREs were mutated, the promoter activity was almost completely abolished (Figure 2-13 A).
These results suggest that both ISREs contribute to the non-canonical expression of Ifit1 by
WNV infection, and they are not redundant.
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Because the two ISREs are not close to each other in the Oas1b promoter, the ISREs
were separately mutated in two constructs, Oas1b (-251, +50) containing both sites and Oas1b (93, +50) containing only the 3′ ISRE. Mutation of the ISRE in the Oas1b (-93, +50) construct
decreased promoter activity by ~68% (Figure 2-13 B). Mutation of either ISRE in the Oas1b (251, +50) construct significantly decreased promoter activity, with mutation of the 3′ ISRE
having a greater negative effect. When both of the Oas1b ISREs were mutated, the promoter
activity was similar to that observed when only the 3′ ISRE was mutated (Figure 2-13 B). These
data indicate that the ISREs play a key role in mediating the non-canonical upregulation of
Oas1b in WNV-infected cells, and that the 3′ ISRE has a more important role than the 5′ one.
However, the data also indicate that the ISREs are not the only sites involved in IFN-independent
gene regulation in this promoter. Comparison of the Oas1b (-299, +50) and Oas1b (-299/-202, 93/+50) constructs showed that even when both ISREs were present, deletion of the enhancer
region between -202 and -93 decreased the promoter activity by more than 50% (Figure 2-13 B).
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Figure 2.13 Effect of ISRE on the IFN-independent activities of the Ifit1 and Oas1b promoters.
The ISREs in (A) Ifit1 and (B) Oas1b promoter fragments were mutated in reporter
constructs as indicated on the left side of the diagram. Transformed (3T3) IFNAR-/- MEFs were
mock-infected or infected with WNV W956 at a MOI of 3. At 3 hpi, cells were co-transfected in
triplicate with one of the mutant ISRE Nluc luciferase reporter constructs and the firefly
luciferase vector pGL4.53 as a transfection control. Cell lysates were prepared at 28 hpi and
luciferase activity was measured. Experiments with each construct were repeated three times.
The Nluc luciferase activity was normalized to the firefly luciferase activity for each construct
sample. Values are mean with SD of a representative experiment from three biological repeats.
The significant differences between each sample were determined with two-way ANOVA with
Tukey’s post hoc test (*, p<0.05).
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2.3.9 ISREs can be activated in an IFN-independent manner
To further confirm that an ISRE can be activated in an IFN-independent manner, the
effect of a WNV infection on the activation of an ISRE luciferase reporter (pISRE-luc)
containing three copies of the ISRE consensus sequence was assessed. IFNAR-/- MEFs were
mock-infected or infected with WNV W956 at a MOI of 3. At 3 hpi, cells were co-transfected
with pISRE-luc and pTK-Rluc (transfection control) construct DNA. The luciferase activity of
the ISRE reporter was induced more than 3-fold by WNV infection (Figure 2-14). The data
confirm that ISREs can be activated in an IFN-independent manner in WNV-infected cells.

Figure 2.14 Activation of the expression of an ISRE reporter in an IFN-independent manner by
WNV infection.
Transformed (3T3) IFNAR-/- MEFs were mock-infected or infected with WNV W956
for 3 h at a MOI of 3 and at 3 hpi, were co-transfected with a 3x ISRE-luc reporter construct
DNA and pGL-TK reporter DNA (transfection control) in triplicate. At 28 hpi, cells were lysed,
and luciferase activity was measured. Values are mean with SD of a representative experiment
from three biological repeats. The statistical significance was evaluated by a student’s t-test with
p<0.01.
2.3.10 Detection of protein complexes binding to the ISREs of Ifit1 promoter by
electrophoretic mobility shift (EMSA)
An EMSA was used to directly investigate whether nuclear proteins in WNV-infected
IFNAR-/- cells can bind to the ISREs of an Ifit1 promoter fragment. The DNA probe consisted
of the Ifit1 promoter region from -103 to -38, which contains two ISREs, was labeled at the 3′
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end with biotin. Nuclear extracts were prepared as described in Materials and Methods from
mock-infected or WNV W956-infected (MOI of 3) IFNAR-/- MEFs harvested at 21 hpi. The
probe was incubated with the nuclear extracts for 1 h, and then the reaction mixtures were
subjected to native PAGE. Two complexes were detected in the mock-infected nuclear extracts
(Figure 2-15, lane 1) while three complexes were detected in the WNV-infected nuclear extracts
(Figure 2-15, lane 7). The unique complex (Complex III) detected in the WNV samples migrated
slower than the other two complexes (Complex II and Complex I) that were detected in all of the
samples. When the unlabeled probe was titrated into the binding reactions, the Complex III band
decreased in intensity in a dose dependent manner in the WNV-infected nuclear extracts and
both the Complex II and Complex I band densities decreased in mock-infected and WNVinfected samples (Figure 2-15, lane 2 to 5, lane 8 to 11). A probe that contained both ISRE core
sequences mutated from GAAA into GTAC was also tested by EMSA. Complex III was not
detected by the mutant probe in the WNV-infected nuclear extract. The formation of Complex I
was detected in both mock-infected and WNV-infected nuclear extracts with the mutant probe,
but Complex II was not detected in neither mock-infected nor WNV-infected nuclear extracts by
the mutant probe. However, an increase of a large slower migrating complex (Complex M) was
observed with the mutant probe in both the mock-infected and WNV-infected nuclear extracts
(Figure 2-15, lane 6 and lane 12). These data indicate that the ISREs are required for the
formation of Complex III in WNV-infected extracts. The formation of Complex II decreased
with increasing concentrations of the unlabeled wild-type probe and did not form with the mutant
probe (Figure 2-15), suggesting that some cell protein(s) in both infected and uninfected cell
nuclear extracts can bind to the ISREs. Complex I formation decreased with increasing
concentrations of unlabeled probe, but was still detected with the ISREs mutant probe, indicating
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that nuclear proteins can also bind to other regions of the probe and do not require protein-DNA
complexes binding at the ISREs to facilitate their binding.

Figure 2.15 Cell proteins in WNV-infected IFNAR-/- MEF nuclear extracts bind to promoter
ISRE motifs.
Transformed (3T3) IFNAR-/- MEFs were mock-infected or infected with WNV W956 at
a MOI of 3, and at 21 hpi, nuclear extracts were prepared. Nuclear extracts (3 µg) were
incubated with biotin-labeled oligonucleotide probes for 1 h at 22°C. The lanes are numbered
below the gel. In lanes 1 to 5 and 8 to 11, a 3′ biotinylated Ifit1 probe that contained two ISREs
and corresponded to the Ifit1 promoter region from -103 to -38 was used. In lanes 2 to 5 and 8 to
11, increasing concentrations of unlabeled probe was added to the reactions. The excess of the
unlabeled probe over labeled probe is indicated. In lanes 6 and 12, labeled probe containing
mutant ISREs was used. The reactions were electrophoresed on native 6% polyacrylamide gels.
The migration positions of the free probe and protein-DNA complexes are indicated by arrows.
The red asterisk indicates the specific complex formed only with the probe containing wild-type
ISREs in WNV-infected nuclear extracts. A representative blot from four independent
experiments is shown.
2.3.11 One or more NF-κB transcription factors bind to the Ifit1 promoter in IFNindependent ISG upregulation mechanism
During canonical IFN signaling, in response to type I IFN binding to its cell surface
receptor, the transcription factor complex ISGF3, which is composed of STAT1, STAT2, and
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IRF9, assembles, translocates to the nucleus and binds to the ISREs in ISG promoters resulting
in upregulation of their expression. However, WNV infection blocks the nuclear translocation of
this complex. Therefore, the proteins found to be binding to the ISRE in WNV-infected, IFNAR/- extracts are not components of the ISGF3 complex. A recent publication reported that IRF5
could bind to a DNA consensus that is similar to that of the ISRE when assisted by NF-κB RelA
(Saliba et al., 2014). The binding of IRF3 to an ISRE after TLR4 activation also requires that
RelA forms a complex with IRF3 (Wietek et al., 2003). It was hypothesized that NF-κB RelA is
involved in the WNV-induced IFN-independent ISG upregulation mechanism by facilitating the
binding of other transcription factors to the ISRE.
The NF-κB family of transcription factors contains five members in mammals: RelA
(p65), RelB, c-Rel, NF-κB1 (p105) and NF-κB2 (p100). p105 and p100 are processed into p50
and p52, respectively (Hayden and Ghosh, 2011). In the canonical NF-κB pathway, when
cytoplasmic IκBα is phosphorylated, it dissociates from the RelA/p50 heterodimer. The
RelA/p50 heterodimer then translocates to the nucleus and binds to NF-κB sites in gene
promoters (Oeckinghaus et al., 2011). An NF-κB inhibitor, caffeic acid phenethyl ester (CAPE),
inhibits the nuclear translocation of the RelA/p50 complex and suppresses its binding to DNA
(Natarajan et al., 1996). The exact mechanism by which CAPE inhibits NF-κB activation is not
clear. The observation that the inhibitory effect of CAPE can be reversed by reducing agents
suggested that a critical sulfhydryl group in NF-κB complex may be modified by CAPE
(Natarajan et al., 1996). As an initial means of studying the possible involvement of NF-κB RelA
in the IFN-independent ISG upregulation mechanism, the effect of CAPE on IFN-independent
Ifit1 promoter activity was investigated. IFNAR-/- MEFs were mock-infected or infected with
WNV W956 at a MOI of 3. Different concentrations of CAPE were added to the culture medium
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immediately after virus absorption. At 3 hpi, cells were co-transfected with Ifit1 (-192, +66)
Nluc luciferase reporter DNA and pGL 4.53 firefly luciferase reporter DNA (transfection
control). At 29 hpi, cells were lysed and luciferase activities were measured. CAPE inhibited the
upregulation of Ifit1 promoter activity by WNV infection in the IFNAR-/- MEFs in a dosedependent manner (Figure 2-16 A). These data suggested that NF-κB plays a role in the
alternative ISG upregulation mechanism.
The effect of CAPE on DNA binding complex formation detected by EMSA was next
analyzed. Different concentrations of CAPE were first added to nuclear extracts from mockinfected or WNV W956-infected MEFs, and incubated at 37°C for 30 min. A 3′ biotinylated Ifit1
promoter -103 to -38 region probe was then added to the binding mixtures, and after incubation
at 22°C for another 1 h, the complexes formed were analyzed by EMSA. Treatment with CAPE
reduced the formation of Complexes I and II in the mock-infected nuclear extracts and of
Complexes I, II and III in the WNV-infected nuclear extracts in a dose dependent manner
(Figure 2-16 B). The data suggest that an NF-κB subunit is involved in each of the three
complexes detected. The formation of Complex II and Complex III, which did not form when an
ISRE mutant probe was used (Figure 2-15), was reduced by the treatment with CAPE (lane 2 to
5, 8 to 11) (Figure 2-16 B). However, the formation of Complex I, which still formed when an
ISRE mutant probe was used (Figure 2-15), was also reduced after the treatment with CAPE
(lane 2 to 5, 8 to 11) (Figure 2-16 B). The data suggest that NF-κB subunits are present in protein
complexes that bind to the ISRE and to ISRE flanking sequences in mock-infected cells as well
as WNV-infected cells. NF-κB subunits also facilitate the upregulation of ISG expression in an
IFN-independent manner in WNV-infected cells.
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Figure 2.16 An NF-κB transcription factor is involved in regulating the non-canonical ISG
upregulation mechanism.
(A) Transformed (3T3) IFNAR-/- MEFs were mock-infected or infected with WNV
W956 at a MOI of 3. The NF-κB inhibitor CAPE was added to the culture medium immediately
after the virus absorption period. At 3 hpi, cells were co-transfected with Ifit1 (-192, +66)
promoter reporter DNA and pGL 4.53 reporter DNA (transfection control) in triplicate. At 29
hpi, cells were lysed, and reporter luciferase activities were measured. The plotted values are the
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mean with SD from one representative experiment of three biological repeats. Significant
differences were determined with a one-way ANOVA with multi-comparisons to the data for the
DMSO treatment sample and Tukey’s post hoc test (****, p<0.0001). (B) Different
concentrations of CAPE were added to the nuclear extract in the binding reaction and incubated
at 37°C for 30 min. A 3′ biotinylated Ifit1 promoter -103 to -38 region probe was then added.
After incubation for 1 h at 22°C, the DNA-protein complexes were analyzed by EMSA. The data
shown are representative of one of two independent repeats.

As an additional means of determining if NF-κB RelA is a component of Complex III, a
supershift assay was performed. Different amounts of an anti-RelA antibody were added to the
nuclear extracts and after incubation on ice for 30 min, the 3′ biotinylated Ifit1 promoter -103 to 38 region probe was added, and the binding reactions were incubated at 22°C for 1 h. The DNAprotein complexes were separated by native PAGE. A slight decrease in the intensity of the
Complex III band was observed when 5 μl of the anti-RelA antibody was added, but lower
concentrations of antibody did not cause a detectable decrease in band density (lane 9) (Figure 217 A). Quantification of the Complex III band intensities confirmed that there was a statistically
significant decrease in the intensity of the Complex III band after incubation with 5 µl anti-RelA
antibody compared to the antibody buffer control (Figure 2-17 B). These data suggest that RelA
is one of the components of Complex III. The lack of detection of a supershift band may be
because of prevention of RelA from binding to the complex due to interaction with the antibody.
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Figure 2.17 NF-κB RelA may be a component of Complex III.
(A) Transformed (3T3) IFNAR-/- MEFs were infected with WNV W956 at a MOI of 3.
At 21 hpi, nuclear extracts were prepared and incubated with the indicated amounts of anti-RelA
antibody, antibody buffer (PBS plus Azide) or rabbit IgG for 30 min on ice. The wild-type
biotin-labeled DNA probe was then added. After incubation for 1 h at 22°C, the DNA-protein
complexes were analyzed by EMSA. Arrows indicate the protein-DNA complexes formed. The
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red asterisk indicates Complex III that forms only with infected nuclear extracts when the wildtype ISREs are present in the probe. (B) Densitometric quantification of the Complex III bands
in the gel shown in panel A.
2.3.12 An IRF protein may interact with NF-κB RelA at ISREs to regulate the IFNindependent ISG upregulation mechanism
The interaction of NF-κB family members with other heterologous transcription factors
occurs either through direct interaction or by the different transcription factor occupying
neighboring sites on a gene promoter (Oeckinghaus et al., 2011). Transcription factors
previously shown to synergistically interact with NF-κB include Sp1, AP-1, STAT3 and
CCAAT/enhancer-binding protein beta (CEBP/β) (Oeckinghaus et al., 2011). RelA and IRF3
form a stable complex that can bind to an ISRE in response to TLR4 but not TLR3 activation
(Wietek et al., 2003). IRF5 can form a complex with RelA, which is required for IRF5-mediated
regulation of tumor necrosis factor (TNF) gene expression at an NF-κB promoter site in dendritic
cells (Krausgruber et al., 2010). In macrophages, IRF5 and RelA form a complex that binds to an
ISRE-like DNA consensus sequence and regulates the expression of inflammatory genes,
including Il-1a, Il-6, and Tnf (Saliba et al., 2014). The sequences of IRF-binding elements (IRFE) in gene promoters share a high degree of homology with the ISRE (Schmid et al., 2010). In
WNV-infected IRF3/5/7-/- MEFs, the level of the IFN-independent ISG response was reduced,
and the ISG induction was not sustained. The data suggest the possibility that IRF3, IRF5, and
IRF7 may be redundantly involved in the IFN-independent mechanism with any one of these
three IRFs being able to function in this role (Figure 2-9).
To directly compare the differences in the proteasome in nuclei of infected and
uninfected cells, nuclear extracts of IRFAR-/- MEFs that were mock-infected or infected with
W956 at a MOI of 3 were prepared at 23 hpi following the protocol described in the Materials
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and Methods. Total amounts of protein in the nuclear extracts were measured with a BCA assay
(ThermoFisher Scientific). Approximately 11 µg of each nuclear extract protein sample was
loaded onto one lane of a 12% NuPAGE Bis-Tris gel, which was electrophoresed with NuPAGE
MOPS SDS buffer (Life Technologies). The electrophoresis was stopped when the samples
migrated ~0.5 cm into the gel. The protein gel was then stained with a colloidal blue staining kit
(Life Technologies) and shipped to the Wistar Institute Proteomics and Metabolomics Facility
(Philadelphia, PA) for MassSpec analysis. The proteins in the mock or WNV infection nuclear
extracts on the gel were excised as a single band and digested with trypsin. The tryptic peptides
were then analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) on a Q
Exactive Plus mass spectrometer (ThermoFisher Scientific). Peptide sequences were identified
using MaxQuant 1.5.2.8 (Ref: PMID 19029910). MS/MS spectra were searched against a
UniProt Mus musculus (September 2016) database. The detected mouse nuclear proteins were
quantified based on the identified peptides using the intensity-based absolute quantification
(iBAQ) method and normalized using the MaxLFQ algorithm to take into account differences in
sample loading (Schwanhausser et al., 2011; Cox et al., 2014). WNV-induced protein fold
change was calculated over mock-infected protein level based on the LFQ intensity of each
protein. STAT1 and STAT2 proteins, which are components of the transcription factor complex
in the canonical JAK-STAT pathway, were not detected by MassSpec in the nuclear extracts of
WNV-infected IFNAR-/- MEFs. This observation is consistent with previous data showing
blockage of STAT protein nuclear translocation in WNV-infected cells (Pulit-Penaloza et al.,
2012b). The levels of RelA in the nucleus were found to be upregulated by WNV infection by 4fold, but neither p50 nor the IRF1, 3, 5 or 7 proteins were detected in the nucleus or cytoplasm
by the MassSpec analysis.
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Western blotting of the same nuclear extracts used for EMSA shown in Figure 2-15 was
used as an alternative method for analyzing whether the levels of the NF-κB components (p50
and RelA) as well as IRF3, IRF5, and IRF7 increased in the nucleus after WNV infection in
IFNAR-/- MEFs. An increase in the nuclear levels of RelA and p50 was observed after WNV
infection (Figure 2-18). The data confirm activation of the NF-κB pathway by WNV-infection.
The levels of the IRF3, IRF5 and IRF7 proteins were higher in the nucleus than in the cytoplasm
in mock-infected cells, and the levels of these proteins in the nucleus increased in the nuclei of
IFNAR-/- MEFs after WNV-infection (Figure 2-18). The data indicate that the observed
increased nuclear location of the NF-κB and IRF proteins after WNV infection is independent of
IFN signaling.

Figure 2.18 The levels of RelA, p50, IRF3, IRF5 and IRF7 proteins increase in the nucleus of
WNV-infected IFNAR-/- MEFs.
The same nuclear extracts used in the EMSA (Figure 2-15) were analyzed by Western
blotting together with an equivalent amount protein of the corresponding cytoplasmic extracts,
which were collected from mock- or WNV-infected IFNAR-/- MEFs (3T3-transformed) at 21
hpi. Protein samples (45 µg) were separated in 10% and 15% SDS-PAGE gel. After transfer, the
proteins on the membrane were detected with corresponding antibodies.
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2.4

Discussion

2.4.1 Cell sensors involved in the alternative ISG upregulation mechanism
After WNV infection, multiple cell sensors, including RIG-I, MDA5, TLR3, TLR7,
TLR8, and DNA sensor cGAS, are activated by viral pathogen-associated molecular patterns
(PAMPs), thus leading to the induction of type I IFN (Suthar et al., 2013; Gack and Diamond,
2016). Among these sensors, RIG-I and MDA5 are considered necessary for detection of a WNV
infection and have nonredundant roles (Errett et al., 2013). This conclusion was reached from
data obtained in studies performed with cells that have a functional IFN-dependent innate
immune system. Data obtained in the present study showed that only basal expression of ISGs
was observed in WNV-infected RIG-I-/-/MDA5-/- MEFs at early and late times after infection,
indicating that either RIG-I or MDA5 sensing is also required to initiate the WNV-induced IFNindependent ISG upregulation mechanism. The data also suggest that other cell sensors are not
required for the alternative antiviral mechanism in WNV-infected cells. The previously reported
data showing that the IFN-independent ISG upregulation mechanism is also reduced in WNVinfected IPS-1-/- MEFs (Pulit-Penaloza et al., 2012b), confirmed the essential role of RIG-I and
MDA5 in detecting WNV infection and IPS-1 in mediating downstream signaling in both the
IFN-dependent and IFN-independent ISG upregulation mechanisms.
The RIG-I-/-/MDA5-/- MEFs and IPS-1-/- MEFs do not produce type I IFN after WNV
infection (Pulit-Penaloza et al., 2012b; Errett et al., 2013), providing a “clean system” for
studying the effect of these factors on the IFN-independent antiviral mechanism. However, the
kinetics of ISG induction in these two types of MEFs after WNV infection differed. In cells
lacking IPS-1, the ISGs are upregulated at 8 hpi, and then the levels progressively decrease
(Pulit-Penaloza et al., 2012b), while ISGs are not upregulated at any time after infection in WNV

91

infected RIG-I-/-/MDA5-/- MEFs (Figure 2-5). IPS-1 is currently considered to be the only
adaptor for RIG-I and MDA5 downstream signaling. The inconsistency in ISG expression
between RIG-I-/-/MDA5-/- MEFs and IPS-1-/- MEFs suggests the possibility that another
unknown adaptor protein(s) can also transduce signaling downstream of RIG-I or MDA5.
The data obtained from the comparison of the WNV W956- and Eg101-induced ISG
expression levels in IFNAR-/- MEFs also support the role of the cell RNA sensors in initiating
the alternative antiviral mechanism. A WNV W956 infection produces higher levels of
“unprotected” viral RNA at early times after infection, which activate the cell RNA sensors
leading to higher induction levels of ISGs than a WNV Eg101 infection (Figure 2-3). The
induced ISGs then work cooperatively to limit the virus yield produced by WNV W956 (Figure
2-4). Interestingly, in W956-infected cells, the mRNA expression levels of Oas1a and Oas1b
progressively decrease after 24 hpi, while no decrease in Oas1a and Oas1b levels is observed in
WNV Eg101-infected cells (Figure 2-3), suggesting that additional factors in WNV-infected
cells are involved in maintaining the activation of the cell sensors.
2.4.2 ISREs are involved in both the IFN-dependent and -independent mechanisms
During the canonical IFN-dependent ISG upregulation mechanism, activation of the
JAK-STAT pathway leads to the transcription factor complex ISGF3 binding to ISREs on the
promoters of ISGs, which activates their expression. However, data obtained in the present study
showed that the ISREs also mediate non-canonical, IFN-independent ISG expression by
interacting with a different transcription factor complex. The finding that the same DNA element
can bind to two distinct sets of proteins in response to a virus infection suggests transcriptional
regulation redundancy that ensures an efficient antiviral system being activated by either the
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IFN-dependent or -independent mechanism. This finding also provides new insights about the
eukaryotic gene regulatory network.
Data obtained in the present study show that Oas1a, Oas1b, Irf7, Ifit1, and Mx1 belong to
the subset of ISGs that are upregulated by WNV-induced IFN-independent mechanism but Mx2
and Rsad2 do not. The numbers and locations of ISREs in the promoters of these ISGs were
compared. The promoters of each of the IFN-independently upregulated ISGs, Oas1a, Oas1b,
Irf7, and Mx1, contain one or two ISREs while the Ifit1 promoter contains three ISREs. The
promoters of Mx2 and Rsad2 also contain one and two ISREs, respectively. Concerning ISRE
location, the promoters of each of these ISGs contain at least one ISRE within 350 bp upstream
of the TSS except for Irf7, which belongs to the IFN-independently upregulated subset of ISGs
(Table 2-5). Differences in the number or locations of the ISREs in the promoters of the ISGs did
not correlate with the ability of the ISG to be upregulated in response to only the IFN-dependent
upregulation mechanism or both the IFN-dependent and IFN-independent upregulation
mechanisms. In the present study, individual mutation of the two ISREs in the Ifit1 and Oas1b
promoters that are located within 350 bp upstream of TSS shows that each of these ISREs is
critical for the IFN-independent upregulation (Figure 2-13). The two ISREs in Ifit1 promoter that
are close to the TSS are 19 nts apart, while the two ISREs in the Oas1b promoter are 219 nts
apart. It is interesting that no matter whether the ISREs are close or not, they both contribute to
the gene upregulation in the IFN-independent mechanism.
Table 2.5 Locations of the ISREs on the promoters of some ISGs
Genea
ISRE site amount
ISRE site upstream of TSSb
Oas1a
one
-15
Oas1b
two
-235, -16
Irf7
one
-661
Ifit1
three
-613, -79, -60
Mx1
two
-912, -318
Mx2
one
-165
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Rsad2
two
-817, -103
The rows shaded pink indicate genes that are upregulated by the IFN-independent mechanism,
while the rows shaded blue indicate genes that are not.
b
The location of the N site, which is next to the 3′GAAA (underlined) in the
5′A/GNGAAANNGAAACT3′ consensus, relative to the TSS of the gene.
a

The finding that not all of the ISREs can be activated by the non-canonical mechanism
suggests that the nts contained in the different ISREs, including the variation of the 5′ GAAA
site and the N nts in the ISRE consensus, may determine the binding partners of the ISRE and
the sequences flanking the ISRE may also play a role. Analysis of additional ISREs, which are
activated by the WNV-induced IFN-independent mechanism, is needed to further investigate the
consensus of the ISREs that can mediate this non-canonical mechanism as well as the sequence
differences between ISREs that can and cannot respond to IFN-independent signaling.
2.4.3 Additional promoter regions are involved in mediating the IFN-independent
mechanism
Although ISREs mediate IFN-independent ISG expression, the present study
demonstrated that regulation mediated by the ISRE works together with other enhancers. Both
constructs Oas1b (-28, +50) and Oas1b (-93, +50) contain the 3′ ISRE. However, the promoter
activity of Oas1b (-28, +50) was quite low, while the enhancer region located from -93 to -28
significantly increased the promoter activity of Oas1b (-93, +50) (Figure 2-12 B). On the other
hand, mutation of this 3′ ISRE decreased the promoter activity of Oas1b (-93, +50) by about 67%
[comparison of Oas1b (-93, +50)-mut ISRE and Oas1b (-93, +50)] (Figure 2-13 B). The data
suggest that the high promoter activity of Oas1b (-93, +50) is due to the effect of the ISRE as
well as the enhancers in the adjacent upstream region between -93 to -28. In another example,
although both of the ISREs in the Oas1b promoter are present in the construct Oas1b (-299/-202,
-93/+50), its promoter activity was still less than 50% of the promoter activity of Oas1b (-299,
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+50) (Figure 2-13 B), demonstrating that the enhancers in the region between -202 to -93 are
also involved in regulating the IFN-independent induction of Oas1b by WNV infection together
with the two ISREs. Similar data were also obtained with the Ifit1 promoter constructs. Although
the two 3′ ISREs contributed more than 80% of the promoter activity of Ifit1 (-192, +66)
[comparison of Ifit1 (-192, +50)-mutate-both-ISRE and Ifit1 (-192, +50)], the enhancers in the
region between -192 to -132 contributed nearly 40% of the promoter activity of Ifit1 (-192, +50)
[comparison of Ifit1 (-192, +50) and Ifit1 (-132, +50)] (Figure 2-11 A, Figure 2-12 A). TFBS
prediction in the enhancer regions of both the Oas1b and Ifit1 promoters, which coordinately
work with the ISREs, revealed a CEBP/β binding site. The transcription factor CEBP/β is has
been shown to synergistically interact with NF-κB (Oeckinghaus et al., 2011). Data obtained in
the present study suggested that NF-κB transcription factors bind to the ISREs in the IFNindependent ISG upregulation mechanism.
2.4.4 The additional promoter regions involved in mediating the IFN-dependent and independent ISG upregulation mechanisms differ
ISREs mediate both IFN-dependent and -independent ISG induction after WNV
infection, but the additional promoter regions involved in these two ISG upregulation
mechanisms are different. In previous study of mapping the Oas1b promoter regions required for
induction by IFN-β, the region from -576 to +50 was shown to have the highest induction
activity, the region from -814 to -576 to contain repressors and the region from -576 to -181 to
contain enhancers (Pulit-Penaloza et al., 2012a). In contrast, data from the present study showed
that for the IFN-independent WNV-induced ISG expression mechanism, the Oas1b promoter
construct containing promoter regions from -299 to +50 showed the highest induction activity,
and the region from -802 to -576 to contain enhancers and the region from -576 to -181 to

95

contain enhancers as well as repressors (Figure 2-12). These data demonstrate that the same
promoter regions have opposite function in response to different cell signaling pathways (Figure
2-19). These opposite regulatory effects are likely due to different repressors and activators
binding to the various DNA elements present.

Figure 2.19 Oas1b promoter regions function differently in response to IFN-dependent and IFNindependent signaling.
The regulatory regions of Oas1b promoter for IFN-dependent signaling were summarized
from previously published data (Pulit-Penaloza et al., 2012a), while the regulatory regions for
WNV-induced IFN-independent signaling were summarized from the data in Figure 2-12. Green
rectangle, ISRE. A, enhancer. R, repressor.
2.4.5 NF-κB and either IRF3, IRF5 or IRF7 work together with additional TFs on ISG
promoters to facilitate IFN-independent gene upregulation
Data obtained in the present study suggested a working model at the transcriptional
regulation level for the non-canonical ISG upregulation mechanism in WNV-infected cells. In
mock-infected IFNAR-/- cells, a particular set of transcription factors, including one or more
NF-κB proteins, bind to the ISREs and flanking regions but only maintain basal levels of
promoter activation. WNV infection activates an additional protein complex binds to the ISREs,
thus inducing higher levels of ISG expression. This new protein complex could form through
replacing either some or all of the proteins already bound to the ISRE under basal conditions,
and could form through recruiting additional proteins to the enhancer regions.
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Data from the present study suggested that the WNV-induced, ISRE-binding protein
complex may include RelA. A crystal structure of IRF proteins bound to a targeted DNA
sequences demonstrated that the GAAA consensus of DNA is critical for IRF3 and IRF7 binding
(Panne et al., 2004; 2007). The mutated ISRE used in the present study contains a disrupted
GAAA consensus. The observation that the unique WNV-induced complex does not form with a
mutated ISRE (Figure 2-15) suggested that IRF3 or IRF7 may also be part of the complex. IRF3
and IRF5 were previously shown to be able to form a complex with RelA (Wietek et al., 2003;
Krausgruber et al., 2010). The observation that the cells lacking IRF3, IRF5 and IRF7 showed
decreased ISG upregulation after WNV infection suggests that IRF3, IRF5, and IRF7 may
redundantly regulate the expression of the ISGs (Figure 2-9). The three IRF proteins, IRF3,
IRF5, and IRF7, as well as RelA, were all shown to be present in the nucleus after WNV
infection (Figure 2-18). Either IRF3, IRF5 or IRF7 may be contained in the unique WNVinduced complex that binds to the ISREs, but whether these IRFs are present as monomers or
dimers is not known.
The data obtained suggest that RelA and an IRF protein may be present in the promoters
of responsive ISGs, but additional enhancer regions identified suggest other proteins are
involved. Transcription co-activator proteins CREB-binding protein (CBP) and its homolog p300
are possible candidates. Phosphorylated IRF3 forms a strong association with CBP and p300 that
facilitates its transcription activation of type I IFN genes (Weaver et al., 1998; Clement et al.,
2008). In Newcastle disease virus-infected cells, IRF5 interacts with CBP and p300, which were
specifically recruited to the IFN-α promoter (Feng et al., 2010). In a study of Sendai virus
infected cells, a virus-activated factor (VAF) complex, which contains IRF3, IRF7, and p300,
bind to ISRE and IRF-E in the IRF7 promoter (Ning et al., 2005).
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3

FUTURE DIRECTIONS

Although the majority of WNV infections in humans are asymptomatic, about 20% of
infected humans experience fever and mild disease symptoms while one in every 150 develops
severe neuroinvasive diseases. Typically mild flu-like disease symptoms resolve after 1 week of
infection, but fatigue, muscle weakness, joint pain and headache can persist for more than 30
days. In the neuroinvasive cases, WNV infection can cause irreversible damage to the central
neuron system (Murray et al., 2011). No approved vaccines or specific therapies for WNV
infections in human are currently commercially available. WNV-host interactions are being
studied to gain additional knowledge to facilitate future development of effective treatments. The
expression of hundreds of ISGs activated by virus-induced IFN constitutes the first line of host
antiviral defense. Although WNV has evolved effective ways of counteracting the host IFN
response, the Brinton lab previously discovered that there is an alternative backup mechanism in
host cells for establishing an antiviral state. In the present study, the WNV-induced IFNindependent antiviral mechanism was further characterized in mouse cells. After a WNV
infection, the host cell cytosolic sensors, RIG-I and MDA5, redundantly detect viral RNA and
signal through their adaptor IPS-1 to downstream transcription factors. In the nucleus, WNVinduced transcription factor complexes bind to ISREs and flanking regions, mediating the
expression of a subset of ISGs. The data obtained in the present study suggest that the WNVinduced ISRE-binding complex contains NF-κB components and either IRF3, IRF5 or IRF7
(Figure 3-1).
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Figure 3.1 Working model for the IFN-independent ISG upregulation mechanism in WNVinfected cells.
After WNV infection, viral RNAs are detected by host cytosolic sensors, RIG-I and
MDA5. The activated sensors signal through their adaptor molecule IPS-1, which ultimately
activates transcription factors. In the nucleus, a unique WNV-induced transcription factor
complex binds to the ISRE on the promoters of a subset of ISGs, thereby activating expression of
these ISGs in an IFN-independent manner. The proteins binding to flanking enhancers of ISREs
also contribute to the IFN-independent upregulation of ISGs.
3.1

Cell signaling pathways that are activated downstream of IPS-1 in WNV-infected
IFNAR-/- MEFs
After WNV infection, cell cytosolic receptors RIG-I and MDA5 are both essential for

detecting virus infection, and transduce signaling through IPS-1 to induce IFN gene expression
(Errett et al., 2013). Data from the present study suggest that the RIG-I/MDA5-IPS-1 pathway is
also used to activate downstream transcription factors, including IRF3, IRF5, or IRF7, and NFκB p50 and RelA, to initiate the WNV-induced IFN-independent antiviral mechanism. However,
the molecules involved in this downstream signaling in WNV-infected IFNAR-/- MEFs are not
known.
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It was shown in previous studies that upon RIG-I or MDA5 activation, IPS-1 recruits
TNFR1-associated death domain protein (TRADD), which coordinates interactions with relevant
downstream molecules. The IPS-1/TRADD complex recruits TNF receptor-associated factor 3
(TRAF3), TRAF-associated NF-κB activator (TANK), and IKKγ, thereby initiating the
activation of TBK1 and IKKε (Saha et al., 2006). The interaction of TRADD with IPS-1 also
orchestrates the formation of a multimeric complex containing Fas-associated death domain
containing protein (FADD), receptor interacting protein 1 (RIP1) that initiates NF-κB activation
(Michallet et al., 2008; Jensen and Thomsen, 2012). The kinases TANK-binding kinase 1
(TBK1) and IκB kinase ε (IKKε) are known to be activated downstream of IPS-1, and they
phosphorylate IRF3 and IRF7, which is required for nuclear translocation of IRF3 and IRF7
(Fitzgerald et al., 2003; Sharma et al., 2003). In addition, TBK1 and IKKε have been implicated
in NF-κB activation. Both of these kinases can catalyze RelA phosphorylation that is essential
for RelA transactivation function (Peters and Maniatis, 2001; Fitzgerald et al., 2003). Future
studies could analyze the involvement of these known IPS-1 downstream molecules and
posttranslational modifications in the WNV-induced IFN-independent ISG upregulation
mechanism.
The involvement of kinases TBK1 and IKKε in upregulating the IFN-independent ISG
expression could be investigated first. Dominant negative mutants of TBK1 and IKKε or specific
kinase inhibitors could be used to knock down these kinases. Alternatively, the two proteins
could be overexpressed from transfected vectors. The effect of knocking down or overexpressing
TBK1 and IKKε could be assayed in the dual luciferase assay system established in the present
study in WNV W956-infected IFNAR-/- MEFs using the Ifit1 (-192, +66) and the Oas1b (-299,
+50) Nluc reporter constructs.
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If TBK1 and/or IKKε are found to be involved in signaling downstream of IPS-1 during
activation of the IFN-independent ISG upregulation mechanism, additional studies could be done
to investigate which molecules are associated with IPS-1 in this mechanism. The candidates are
TRADD, TRAF3, TANK, IKKγ, FADD, and RIP1. The association of each of these proteins
with endogenous IPS-1 could be investigated by immunoprecipitation using an antibody to IPS-1
and immunoblotting with antibodies for each candidate in cell lysates of WNV W956-infected
IFNAR-/- MEFs. The involvement of these proteins in IPS-1 downstream signaling could also be
studied by overexpressing each protein together with the IPS-1 protein and evaluating the effect
in the dual luciferase system established in the present study.
3.2

The subgroup of ISREs and other DNA regulatory elements that can be activated by
the IFN-independent ISG upregulation mechanism
The WNV-induced IFN-independent ISG upregulation mechanism is mediated through

the ISRE on the promoters of the ISGs that are upregulated. However, only a subset of ISGs can
be upregulated by this mechanism, indicating that only this subset contains the ISREs that can be
activated by the IFN-independent as well as the IFN-dependent mechanism. The subgroup of
ISREs could be studied to try to identify possible unique characteristics that are functionally
relevant. In the present study, the ISRE sequences analyzed were from only five ISGs, including
Oas1a, Oas1b, Irf7, Ifit1, and Mx1. Among these, only the five ISRE sites that are on the
promoters of Ifit1 and Oas1b were functionally tested during the IFN-independent activation. To
obtain a more accurate sequence consensus of this subgroup of ISREs, additional ISGs
responsive to the IFN-independent mechanism would need to be identified to compare a larger
number of the functional ISRE sequences. A microarray analysis was previously performed on
the samples collected from WNV-infected, wild-type MEFs (Scherbik et al., 2007b), which
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detected both IFN-dependent and IFN-independent upregulated ISGs and therefore did not allow
unambiguous detection of ISGs upregulated by the IFN-independent mechanism. To obtain a
complete list of the ISGs upregulated by WNV in IFNAR-/- MEFs, an RNA-seq analysis could
be performed. The ISREs of these ISGs could then be tested to confirm their ability to respond to
the IFN-independent induction mechanism by a mutation in promoter constructs used in the
luciferase reporter system. Next, the core and flanking sequences of all the ISREs that respond to
the IFN-independent mechanism could be subjected to bioinformatics analysis to obtain a
consensus sequence. If a characteristic consensus can be found, this information would be added
to TFBS databases as well as to the gene regulation network databases to provide foundational
information for other studies.
The data obtained in the present study suggested that additional regulatory elements on
the ISG promoters besides the ISREs are involved in the IFN-independent ISG upregulation
mechanism in WNV-infected MEFs. These additional regulatory elements could be studied to
obtain a complete picture of the factors involved in IFN-independent ISG upregulation. The
Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq)
could be used to investigate genome-wide accessible regions and to map regions of transcriptionfactor binding and nucleosome positioning on responsive ISG promoters in WNV-infected
IFNAR-/- MEFs (Buenrostro et al., 2013). The derived sequences of transcription-factor binding
regions of the upregulated ISGs would be analyzed by computational motif discovery methods to
search for potential transcriptional regulatory elements mediating the WNV-induced IFNindependent ISG upregulation. The Oas1b and Ifit1 promoter mapping data obtained in the
present this study could be used to confirm the ATAC-seq analysis and computational analysis
results.
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3.3

A novel WNV-induced ISRE-binding protein complex involved in the IFNindependent mechanism
During IFN-dependent ISG upregulation, activation of the JAK-STAT pathway leads to

the transcription factor complex ISGF3 that consists of p-STAT1, p-STAT2, and IRF9, binding
to the ISREs on the promoters of ISGs and upregulating their expression. However, the nuclear
translocation of the transcription factor complex ISGF3 is blocked in WNV-infected human and
mouse cells (Keller et al., 2006; Laurent-Rolle et al., 2010; Pulit-Penaloza et al., 2012b).
Moreover, STAT1, STAT2, and IRF9 were not detected in the nuclear extracts of WNV-infected
IFNAR-/- MEFs by MassSpec in the present study and STAT1 and STAT2 were not previously
detected in nuclei of WNV-infected, wild-type MEFs by immunofluorescence assay (IFA) or in
nuclear extracts by Western blotting (Pulit-Penaloza et al., 2012b). Therefore, the WNV-induced
ISRE-binding protein complex in the IFN-independent mechanism does not contain STAT1,
STAT2 or IRF9. Data from the present study suggest that NF-κB RelA and IRF proteins are
present in the novel virus-induced complex that binds to the ISREs in the promoters of
responsive ISGs. Previous studies suggested that a RelA/IRF3 or RelA/IRF5 complex can bind
to an ISRE after bacterial LPS treatment of cells (Wietek et al., 2003; Saliba et al., 2014). In the
present study, NF-κB components were shown to mediate ISRE-driven ISG expression in the
context of virus infection. It was suggested that NF-κB RelA, either IRF3, IRF5 and IRF7, and
some other transcription co-activator proteins, such as CBP and p300, are present in this WNVinduced ISRE-binding complex. The components of this complex could be elucidated by a pulldown assay using the biotin/streptavidin affinity system in combination with MassSpec analysis
of the pulled down proteins. The DNA probes containing ISREs that were used in the EMSA
assay in this present study would be biotin-labeled, mixed with the nuclear extracts of WNV-
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infected IFNAR-/- MEFs. Next, the protein-DNA complex formed will be pulled down with
streptavidin magnetic beads making use of the high affinity biotin-streptavidin bond. The
proteins associated with the ISREs can then be identified with MassSpec. The probe with
mutated ISREs would be used as a negative control to eliminate non-specific binding proteins in
the MassSpec results. After the components of the WNV-induced ISRE-binding complex are
identified, their roles in regulating the IFN-independent ISG upregulation could be confirmed by
Chromatin immunoprecipitation (ChIP) assay in WNV-infected IFNAR-/- MEFs if ChIP grade
antibodies are available.
After the components of the WNV-induced ISRE binding complex are identified, how
this complex is assembled could next be investigated. The domains of individual components of
the complex would be studied first. All IRF proteins share a common DNA-binding domain
(DBD) while they each contain a unique IRF association domain (IAD) that is responsible for
interacting with other IRF proteins and other factors (Taniguchi et al., 2001). RelA has a
dimerization domain (DD), a carboxy-terminal transactivation domain (TAD), and a Rel
homology domain (RHD) that is conserved among all NF-κB proteins and is responsible for
DNA binding and interaction with IκB (Oeckinghaus and Ghosh, 2009). When forming a
complex with a heterologous transcription factor, RelA can provide its TAD for regulating gene
expression (Yang et al., 2007). IRF3 has been shown to bind to the RHD of RelA, whereas the
IAD of IRF5 and the DD of RelA are critical for the interaction of IRF5 and RelA (Ogawa et al.,
2005; Saliba et al., 2014). RelA has been found to interact with CBP/p300 via its DBD and TAD
(Mukherjee et al., 2013). The domains of IRFs, RelA and other components that are important
for the formation of the WNV-induced ISRE binding complex could be identified by
coimmunoprecipitation assays with each truncated protein exogenously expressed in WNV-
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infected mouse IFNAR-/- cells. The conformation of the ISRE-binding complex could be studied
using structural approaches. In the canonical NF-κB pathway, the NF-κB heterodimer RelA/p50
binds to the NF-κB site containing the consensus sequence 5′-GGGRNYYYCC-3′ (R = A or G,
Y = C or T, N = any base) (Chen and Ghosh, 1999). Notably, although RelA may be involved in
the ISRE-binding complex, this consensus sequence was not found in the ISRE-containing probe
used in the EMSA experiments of the present study. It is possible that RelA adopts a novel
conformation and binds to a DNA sequence that is different from the NF-κB consensus
sequence. A previous crystallization study suggested that one of the RelA monomers in the RelA
homodimer can bind to te DNA sequence 5′-NGGAA-3′ (Chen et al., 2000), which is also a
portion of the ISRE consensus. IRF3 and IRF7 usually bind to DNA as a homodimer or
heterodimer, and each IRF interacts with a GAAA consensus sequence. It is not clear how many
IRF proteins are present in the WNV-induced, ISRE-binding complex. The structure of the
complex binding to the ISRE-containing DNA probe could be studied by co-crystallization.
3.4

The antiviral effect of the alternative ISG upregulation mechanism
The expression of hundreds of ISGs establishes an antiviral state in virus-infected IFN-

competent cells. The ISGs, which have diverse antiviral functions, can work together to
negatively affect each step of a virus life cycle in infected host cells. The antiviral activities of
each ISG are not equal, with some being strong antiviral inhibitors while many being modest
inhibitors. The magnitude of the antiviral activity of two ISGs expressed together is usually
greater than that of either gene expressed alone (Schoggins and Rice, 2011; Schoggins et al.,
2011). Moreover, the antiviral activities of each ISG vary for different viruses. The present study
demonstrated that when the subset of ISGs upregulated by the IFN-independent antiviral
mechanism is induced to a higher level at early times after WNV W956 infection than that after
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WNV Eg101 infection, the antiviral activities of the ISGs work cooperatively to limit the yield of
WNV W956. Although the inhibition effect on WNV W956 virus yield of the IFN-independent
antiviral mechanism is not as significant as the IFN-dependent antiviral state (Scherbik et al.,
2013), the antiviral function of the alternative antiviral response could be studied.
Both the IFN-dependent and IFN-independent antiviral responses are not activated in
WNV-infected RIG-I-/-/MDA5-/- MEFs, and only the IFN-dependent antiviral response is not
activated in WNV-infected IFNAR-/- MEFs. Therefore, virus yields that are produced by WNV
W956 in RIG-I-/-/MDA5-/- MEFs and IFNAR-/- MEFs could be compared to evaluate the
function of the backup IFN-independent antiviral response. If the key transcription factor of the
IFN-independent antiviral mechanism is identified, this protein could be knocked down or
knocked out in IFNAR-/- MEFs to eliminate the IFN-independent mechanism, and WNV virus
yield could be used to evaluate the antiviral effect of the IFN-independent mechanism.
Whether the alternative ISG upregulation mechanism responds to other virus infections
could also be investigated. JEV could be used to investigate to see if the IFN-independent
mechanism could be induced by another flavivirus through assaying its ability to induce the
subset of ISGs in IFNAR-/- MEFs. The IFN-independent mechanism could also be investigated
in IFNAR-/- MEFs infected with other RNA viruses, including Sendai virus and vesicular
stomatitis virus (with a negative-sensed single-stranded RNA genome), as well as Sindbis virus
(with a positive-sensed single-stranded RNA genome). In addition, the alternative ISG
upregulation mechanism could be investigated in human cells. A human cell line that only has
the IFN-independent antiviral response could be obtained by knocking out the type I IFN
receptor using CRISPR. The upregulation of human orthologs of the subset of ISGs could be
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investigated in human IFNAR-/- cells infected with WNV, JEV and other RNA viruses that
could induce this alternative antiviral response in IFNAR-/- MEFs.

SIGNIFICANCE
The results of the present study extend knowledge of host antiviral mechanisms. Analysis
of the host cellular factors and TFBS involved in a non-canonical ISG upregulation mechanism
furthers the understanding of host antiviral responses against WNV infection. The findings of
this study extend knowledge about viral detection, signaling activation and gene induction during
the innate immune responses against virus infections. Many flaviviruses cause significant human
morbidity and mortality around the world, but there are no effective antiviral therapies. Because
most viruses have evolved ways to counteract the host IFN system, the knowledge gained in this
study about an alternative host cell “backup” response provides new insights for future studies on
host antiviral mechanisms and for the development of future antiviral therapies that target WNV
and possibly, also other flaviviruses.
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